Programme
ECV2016_main-programme
ECV2016_main-programme
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Final <strong>Programme</strong><br />
October<br />
19–22, 2016<br />
Congress Center Hamburg<br />
Germany
2<br />
6 th<br />
European Congress of Virology
Content<br />
Page<br />
Imprint<br />
Words of Welcome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 5<br />
Committees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 8<br />
Plenary / Keynote Lecturers. . . . . . . . . . . . . . . . . . . . . . . . P. 10<br />
Chairpersons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 11<br />
Awards/Travel Grant Winners . . . . . . . . . . . . . . . . . . . . . . P. 13<br />
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 15<br />
<strong>Programme</strong> Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 16<br />
Detailed <strong>Programme</strong> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 20<br />
Poster Exhibition and Poster Sessions. . . . . . . . . . . . . . . . P. 33<br />
Poster Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 34<br />
Speaker’s Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 47<br />
Congess Dinner & Networking Event . . . . . . . . . . . . . . . . P. 52<br />
Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 53<br />
Sponsors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 55<br />
Exhibition List . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 56<br />
Exhibition Floor Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 57<br />
Congress Center Hamburg Overview . . . . . . . . . . . . . . . . P. 59<br />
Notes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. 60<br />
Organisers:<br />
European Society for Virology (ESV)<br />
Heinrich Pette Institute,<br />
Leibniz Institute for Experimental<br />
Virology<br />
Conference Chair:<br />
Prof. Joachim Hauber<br />
Heinrich Pette Institute<br />
Leibniz Institute for<br />
Experimental Virology<br />
Martinistraße 52<br />
20251 Hamburg, Germany<br />
E-mail:<br />
ecv2016@hpi.uni-hamburg.de<br />
Web: www.hpi-hamburg.de<br />
Congress Organisation,<br />
Exhibition & Sponsoring,<br />
Congress Dinner:<br />
INTERPLAN Congress, Meeting<br />
& Event Management AG<br />
Rebecca Lefers<br />
Kaiser-Wilhelm-Str. 93<br />
20355 Hamburg, Germany<br />
E-mail: ecv2016@interplan.de<br />
Web: www.interplan.de<br />
Advertsing:<br />
Bernhard Nocht Institute for<br />
Tropical Medicine<br />
Centre for Structural Systems<br />
Biology<br />
Fraunhofer IME ScreeningPort<br />
Heinrich Pette Institute,<br />
Leibniz Institute for Experimental<br />
Virology<br />
Life Science Nord Management<br />
GmbH<br />
MSD SHARP & DOHME GMBH<br />
QIAGEN GmbH<br />
Takara Bio Europe<br />
Zymo Research Europe GmbH<br />
3
4<br />
6 th<br />
European Congress of Virology
Words of Welcome<br />
Dear attendees, dear colleagues and dear friends,<br />
Welcome to the Free and Hanseatic City of Hamburg, the site of the<br />
6th European Congress of Virology (ECV2016). Your presence here is<br />
highly appreciated and greatly enhances the intellectual and social<br />
vibrancy of the conference.<br />
The ECV2016 couldn’t take place at a more appropriate or better<br />
time, from 19-22 October 2016. Just to give a few examples, the frequent<br />
emergence or re-emergence of zoonotic or vector-borne viral<br />
diseases, such as Zika, Ebola or MERS-CoV, the clinical implementation<br />
of a truly curative strategy for HCV infection, or the development<br />
of novel and stunning genome editing technologies, which may soon<br />
allow the direct targeting and subsequent eradication of persistent<br />
viruses, has recently moved virology, the field of our professional interest,<br />
into greater focus within society in general.<br />
In the light of such exceptional scientific and clinical developments, it is the intention of the organizers,<br />
the European Society of Virology (ESV) and, locally, the Heinrich Pette Institute, Leibniz Institute for<br />
Experimental Virology (HPI), that this congress effectively bridges the various aspects of basic, translational,<br />
clinical, veterinary and plant virology. We strongly believe that the programme of ECV2016 will<br />
inspire early, mid and late-career virologists alike.<br />
Such an event cannot be organized without external sponsorship. We therefore greatly appreciate the<br />
financial support of corporations and foundations. Without them, ECV2016 wouldn’t be such a vibrant<br />
event. You should definitively visit the fully integrated ECV2016 sponsor exhibition area.<br />
The venue, the Congress Center Hamburg (CCH), is located right in the centre of Hamburg, Germany’s<br />
youthful and tolerant waterside metropolis. Please enjoy the 6th European Congress of Virology and this<br />
outstanding location during your visit.<br />
On behalf of the Local Organizing Committee<br />
Joachim Hauber<br />
President of ECV2016<br />
5
6<br />
6 th<br />
European Congress of Virology
Words of Welcome<br />
Dear colleagues,<br />
In the occasion of the 6th European Congress of Virology (ECV2016),<br />
it is my great pleasure to welcome you and to illustrate the aim of the<br />
European Society for Virology (ESV).<br />
ESV provides a forum for scientists active in all aspects of Virology.<br />
The aim of the Society is to advance the art and science of Virology<br />
and to promote and stimulate the exchange of information and collaboration<br />
among individual scientists as well as among national and<br />
international associations of Virology throughout Europe.<br />
As in the previous editions, ECV will cover many topics of Virology,<br />
providing insights into molecular pathogenesis, structural biology,<br />
infection and immunity, epidemiology, advanced therapies and prevention,<br />
biotechnology. Talks will be presented by keynote speakers<br />
of indisputable reputation and the scientific programme is really outstanding.<br />
Furthermore, this ECV will be the perfect opportunity for reinforcing or setting up old and new<br />
collaborations among European virologists.<br />
In addition to the scientific aspects, ECV will also be instrumental for the growth of our Society by voting<br />
the new governing boards, by deciding the seats of future ECVs, by proposing new strategies in order to<br />
generate new professional opportunities and make Virology in Europe more attractive for young investigators<br />
and influential at all Institutional levels.<br />
While sincerely thanking you for your participation, I wish you a stimulating, fruitful and enjoyable 6th<br />
European Congress of Virology.<br />
Giorgio Palù<br />
President ESV<br />
7
6 th<br />
European Congress of Virology<br />
Committees<br />
Scientific Committee<br />
Allen, Todd<br />
Altfeld, Marcus<br />
Berkhout, Ben<br />
Blanc, Stéphane<br />
Brune, Wolfram<br />
Cadar, Daniel<br />
Campadelli-Fiume, Gabriella<br />
Cullen, Bryan R.<br />
Delwart, Eric<br />
Dobner, Thomas<br />
Drosten, Christian<br />
Eberhard, Johanna M.<br />
Feldmann, Heinz<br />
Fischer, Nicole<br />
Fleckenstein, Bernhard<br />
Frahm, Thomas<br />
Gabriel, Gülsah<br />
Geijtenbeek, Teunis B.<br />
Greber, Urs<br />
Grünewald, Kay<br />
Günther, Stefan<br />
Haberl, Annette<br />
Harrer, Thomas<br />
Herker, Eva<br />
Hirsch, Hans<br />
Kaiser, Rolf<br />
Klein, Florian<br />
Koopmans, Marion<br />
Cambridge MA, USA<br />
Hamburg, Germany<br />
Amsterdam, The Netherlands<br />
Montpellier, France<br />
Hamburg, Germany<br />
Hamburg, Germany<br />
Bologna, Italy<br />
Durham NC, USA<br />
San Francisco CA, USA<br />
Hamburg, Germany<br />
Bonn, Germany<br />
Hamburg, Germany<br />
Hamilton MT, USA<br />
Hamburg, Germany<br />
Erlangen, Germany<br />
Hamburg, Germany<br />
Hamburg, Germany<br />
Amsterdam, The Netherlands<br />
Zurich, Switzerland<br />
Hamburg, Germany<br />
Hamburg, Germany<br />
Frankfurt, Germany<br />
Erlangen, Germany<br />
Hamburg, Germany<br />
Basel, Switzerland<br />
Cologne, Germany<br />
Cologne, Germany<br />
Rotterdam, The Netherlands<br />
Kräusslich, Hans-Georg<br />
Lavillette, Dimitri<br />
Liljeström, Peter<br />
Malim, Michael H.<br />
Masucci, Maria G.<br />
Mettenleiter, Thomas<br />
Mölling, Karin<br />
Palù, Giorgio<br />
Pantaleo, Guiseppe<br />
Parissi, Vincent<br />
Puchhammer, Elisabeth<br />
Rey, Félix A.<br />
Rivas, Carmen<br />
Rockstroh, Jürgen<br />
Schulz, Thomas<br />
Schulze zur Wiesch, Julian<br />
Sodeik, Beate<br />
Stellbrink, Hans-Jürgen<br />
Sutter, Gerd<br />
Tannich, Egbert<br />
Tommasino, Massimo<br />
Tordo, Noël<br />
Trkola, Alexandra<br />
Uetrecht, Charlotte<br />
van der Poel, Wim H.<br />
van der Vlugt, René A.A.<br />
Wagner, Ralf<br />
Wolf, Dana<br />
Heidelberg, Germany<br />
Shanghai, China<br />
Stockholm, Sweden<br />
London, UK<br />
Stockholm, Sweden<br />
Greifswald, Germany<br />
Berlin, Germany<br />
Padova, Italy<br />
Lausanne, Switzerland<br />
Bordeaux, France<br />
Vienna, Austria<br />
Paris, France<br />
Madrid, Spain<br />
Bonn, Germany<br />
Hannover, Germany<br />
Hamburg, Germany<br />
Hannover, Germany<br />
Hamburg, Germany<br />
Munich, Germany<br />
Hamburg, Germany<br />
Lyon, France<br />
Paris, France<br />
Zurich, Switzerland<br />
Hamburg, Germany<br />
Wageningen, The Netherlands<br />
Wageningen, The Netherlands<br />
Regensburg, Germany<br />
Jerusalem, Israel<br />
Local Organizing Committee<br />
Haller, Kerstin<br />
Hauber, Joachim<br />
Neumann, Ute<br />
Schewe, Knud<br />
Schulze zur Wiesch, Julian<br />
Heinrich Pette Institute, Hamburg, Germany<br />
Heinrich Pette Institute, Hamburg, Germany<br />
Heinrich Pette Institute, Hamburg, Germany<br />
Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany<br />
University Medical Center Eppendorf, Hamburg, Germany<br />
8
ESV Board Members<br />
President<br />
Palù, Giorgio<br />
First Vice-President<br />
Tordo, Noël<br />
Second Vice-President<br />
Berkhout, Ben<br />
Treasurer<br />
Lavillette, Dimitri<br />
Secretary General<br />
Fleckenstein, Bernhard<br />
University of Padova, School of Medicine, Padova, Italy<br />
Institut Pasteur, Paris, France<br />
University of Amsterdam, Amsterdam, The Netherlands<br />
Institut Pasteur Shanghai, Shanghai, China<br />
University of Erlangen-Nuremberg, Erlangen, Germany<br />
ESV Advisory Council<br />
Elected Members<br />
Bartenschlager, Ralf<br />
Domingo, Esteban<br />
Duprex,W. Paul<br />
Greber, Urs<br />
Koopmans, Marion<br />
Landolfo, Santo<br />
Lina, Bruno<br />
Mertens, Thomas<br />
Mettenleiter, Thomas<br />
Osterhaus, Albert<br />
Svensson, Lennart<br />
Wolf, Dana<br />
University Hospital Heidelberg, Heidelberg, Germany<br />
Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain<br />
Boston University School of Medicine, Boston, MA, USA<br />
University of Zurich, Zurich, Switzerland<br />
Erasmus MC, Rotterdam, The Netherlands<br />
University of Turin, Turin, Italy<br />
Centre de Biologie et de Pathologie Est, Lyon, France<br />
University Hospital of Ulm, Ulm, Germany<br />
Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany<br />
University of Veterinary Medicine Hannover, Hannover, Germany<br />
University of Linköping, Linköping, Sweden<br />
Hadassah University Hospital, Jerusalem, Israel<br />
Chairperson of the Award Committee<br />
Skehel, John<br />
The Francis Crick Instiute, London, UK<br />
Chairperson of the Meetings Committee<br />
Campadelli-Fiume, Gabriela University of Bologna, Bologna, Italy<br />
9
6 th<br />
European Congress of Virology<br />
Plenary / Keynote Lecturers:<br />
Todd Allen<br />
Ragon Institute of MGH, MIT and Harvard, Cambridge MA, USA<br />
Graciela Andrei<br />
Rega Institute, KU Leuven, Belgium<br />
Ralf Bartenschlager<br />
University Hospital Heidelberg, Heidelberg, Germany<br />
Thomas F. Baumert<br />
INSERM, University of Strasbourg, Strasbourg, France<br />
Martin Beer<br />
Friedrich-Loeffler-Institute, Greifswald-Insel Riems, Germany<br />
Paul Benn<br />
ViiV Healthcare, London, UK<br />
Clarisse Berlioz-Torrent<br />
INSERM, Paris, France<br />
Stéphane Blanc<br />
NRA-CIRAD-Supagro, Montpellier, France<br />
Frank Buchholz<br />
TU Dresden, Dresden, Germany<br />
Gabriela Campadelli-Fiume University of Bologna, Bologna, Italy<br />
Miles W. Carroll<br />
Public Health England, Salisbury, UK<br />
Susanna Chiocca<br />
European Institute of Oncology, Milano, Italy<br />
Bryan R. Cullen<br />
Duke University Medical Center, Durham NC, USA<br />
Ward De Spiegelaere<br />
Ghent University, Belgium<br />
Eric Delwart<br />
University of California, San Francisco CA, USA<br />
Christian Drosten<br />
University of Bonn, Bonn, Germany<br />
Denis Fargette<br />
IRD, Université Montpellier 2, Montpellier, France<br />
Heinz Feldmann<br />
NIAID, NIH, Hamilton MT, USA<br />
Don Ganem<br />
Novartis Institutes for Biomedical Research, Emeryville CA, USA<br />
J. Victor Garcia University of North Carolina, Chapel Hill NC, USA<br />
Teunis B. Geijtenbeek<br />
University of Amsterdam, Amsterdam, The Netherlands<br />
Philip Goulder<br />
University of Oxford, Oxford, UK<br />
Urs Greber<br />
University of Zurich, Zurich, Switzerland<br />
Hans Hirsch<br />
University of Basel, Basel, Switzerland<br />
Michael J. Imperiale<br />
University of Michigan, Ann Arbor MI, USA<br />
Rolf Kaiser<br />
University Hospital Cologne, Cologne, Germany<br />
Paul Kellam<br />
Welcome Trust Sanger Institute, Cambridge, UK<br />
Marion Koopmans<br />
Erasmus MC, Rotterdam, The Netherlands<br />
Helen M. Lazear<br />
University of North Carolina, Chapel Hill NC, USA<br />
Peter Liljeström<br />
Karolinska Institutet, Stockholm, Sweden<br />
Vishwanath R. Lingappa<br />
Prosetta Biosciences, San Francisco CA, USA<br />
Michael H. Malim<br />
King’s College London, London, UK<br />
Maria Masucci<br />
Karolinska Institutet, Stockholm, Sweden<br />
Thomas Mettenleiter<br />
Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany<br />
Christian Münz<br />
University of Zurich, Zurich, Switzerland<br />
Albert Osterhaus<br />
University of Veterinary Medicine Hannover, Hannover, Germany<br />
Guiseppe Pantaleo<br />
University of Lausanne, Lausanne, Switzerland<br />
Anna Papa<br />
Aristotle University of Thessaloniki, Thessaloniki, Greece<br />
Sven Pischke<br />
University Medical Center Eppendorf, Hamburg, Germany<br />
Alexander Ploss<br />
Princeton University, Princeton NJ, USA<br />
Félix A. Rey<br />
Institut Pasteur, Paris, France<br />
Carmen Rivas<br />
CIMUS USC, Santiago de Compostela, Spain<br />
Jürgen Rockstroh<br />
Bonn University Hospital, Bonn, Germany<br />
Massimo Tommasino<br />
International Agency for Research on Cancer, Lyon, France<br />
Noël Tordo<br />
Institut Pasteur, Paris, France<br />
Jonathan Towner<br />
CDC, Atlanta GA, USA<br />
Alexandra Trkola<br />
University of Zurich, Zurich, Switzerland<br />
Stephan Urban<br />
University Hospital Heidelberg, Heidelberg, Germany<br />
Wim H. van der Poel<br />
Wageningen University, Lelystad, The Netherlands<br />
Dana Wolf<br />
Hadassah Medical Center, Jerusalem, Israel<br />
10
Chairpersons:<br />
Marylyn M. Addo<br />
Todd Allen<br />
Marcus Altfeld<br />
Ralf Bartenschlager<br />
Thomas F. Baumert<br />
Ben Berkhout<br />
Stéphane Blanc<br />
Wolfram Brune<br />
Daniel Cadar<br />
Gabriela Campadelli-Fiume<br />
Bryan R. Cullen<br />
Olaf Degen<br />
Eric Delwart<br />
Thomas Dobner<br />
Christian Drosten<br />
Denis Fargette<br />
Heinz Feldmann<br />
Nicole Fischer<br />
Bernhard Fleckenstein<br />
Gülsah Gabriel<br />
Teunis B. Geijtenbeek<br />
Urs Greber<br />
Stefan Günther<br />
Kay Grünewald<br />
Adam Grundhoff<br />
Annette Haberl<br />
Thomas Harrer<br />
Hans Hirsch<br />
Rolf Kaiser<br />
Florian Klein<br />
Marion Koopmans<br />
Hans-Georg Kräusslich<br />
Dimitri Lavillette<br />
Ulrike C. Lange<br />
Peter Liljeström<br />
Marc Lütgehetmann<br />
Michael H. Malim<br />
Maria Masucci<br />
Thomas Mettenleiter<br />
Karin Mölling<br />
Cesar Muñoz-Fontela<br />
Albert Osterhaus<br />
Giorgio Palù<br />
Vincent Parissi<br />
Guiseppe Pantaleo<br />
Elisabeth Puchhammer<br />
Félix A. Rey<br />
Carmen Rivas<br />
Jürgen Rockstroh<br />
Thomas Schulz<br />
Julian Schulze zur Wiesch<br />
Beate Sodeik<br />
Hans-Jürgen Stellbrink<br />
Gerd Sutter<br />
Massimo Tommasino<br />
Noël Tordo<br />
Alexandra Trkola<br />
Klaus Überla<br />
Wim H. van der Poel<br />
René A.A. van der Vlugt<br />
Ralf Wagner<br />
Dana Wolf<br />
University Medical Center Eppendorf, Hamburg, Germany<br />
Ragon Institute of MGH, MIT and Harvard, Cambridge MA, USA<br />
Heinrich Pette Institute, Hamburg, Germany<br />
University Hospital Heidelberg, Heidelberg, Germany<br />
INSERM, University of Strasbourg, Strasbourg, France<br />
University of Amsterdam, Amsterdam, The Netherlands<br />
INRA-CIRAD-Supagro, Montpellier, France<br />
Heinrich Pette Institute, Hamburg, Germany<br />
Bernhard Nocht Institute, Hamburg, Germany<br />
University of Bologna, Bologna, Italy<br />
Duke University Medical Center, Durham NC, USA<br />
University Medical Center Eppendorf, Hamburg, Germany<br />
University of California, San Francisco CA, USA<br />
Heinrich Pette Institute, Hamburg, Germany<br />
University of Bonn, Bonn, Germany<br />
IRD, Université Montpellier 2, Montpellier, France<br />
NIAID NIH, Hamilton MT, USA<br />
University Medical Center Eppendorf, Hamburg, Germany<br />
University of Erlangen-Nürnberg, Erlangen, Germany<br />
Heinrich Pette Institute, Hamburg, Germany<br />
University of Amsterdam, Amsterdam, The Netherlands<br />
University of Zurich, Zurich, Switzerland<br />
Bernhard Nocht Institute, Hamburg, Germany<br />
Heinrich Pette Institute, Hamburg, Germany<br />
Heinrich Pette Institute, Hamburg, Germany<br />
HIVCenter University of Frankfurt, Frankfurt, Germany<br />
University of Erlangen-Nürnberg, Erlangen, Germany<br />
University of Basel, Basel, Switzerland<br />
University Hospital Cologne, Cologne, Germany<br />
University Hospital Cologne, Cologne, Germany<br />
Erasmus MC, Rotterdam, The Netherlands<br />
University of Heidelberg, Heidelberg, Germany<br />
Institut Pasteur Shanghai, Shanghai, China<br />
University Medical Center Eppendorf, Hamburg, Germany<br />
Karolinska Institutet, Stockholm, Sweden<br />
University Medical Center Eppendorf, Hamburg, Germany<br />
King’s College London, London, UK<br />
Karolinska Institutet, Stockholm, Sweden<br />
Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany<br />
MPI Genetics, Berlin, Germany<br />
Heinrich Pette Institute, Hamburg, Germany<br />
University of Veterinary Medicine Hannover, Hannover, Germany<br />
University of Padova, Padova, Italy<br />
CNRS, Bordeaux 2 University, Bordeaux, France<br />
University of Lausanne, Lausanne, Switzerland<br />
Medical University Vienna, Vienna, Austria<br />
Institut Pasteur, Paris, France<br />
CIMUS USC, Santiago de Compostela, Spain<br />
Bonn University Hospital, Bonn, Germany<br />
Hanover Medical School, Hannover, Germany<br />
University Medical Center Eppendorf, Hamburg, Germany<br />
Hanover Medical School, Hannover, Germany<br />
ICH, Hamburg, Germany<br />
Ludwig Maximilians University, Munich, Germany<br />
International Agency for Research on Cancer, Lyon, France<br />
Institut Pasteur, Paris, France<br />
University of Zurich, Zurich, Switzerland<br />
University of Erlangen-Nürnberg, Erlangen, Germany<br />
Wageningen University, Lelystad, The Netherlands<br />
Wageningen University, Wageningen, The Netherlands<br />
University of Regensburg, Regensburg, Germany<br />
Hadassah Medical Center, Jerusalem, Israel<br />
11
12<br />
6 th<br />
European Congress of Virology
Awards<br />
European Virology Award (EVA) of the European Society of Virology<br />
Prof. Ralf Bartenschlager<br />
New insights into the flavivirus replication cycle:<br />
Implications for antiviral treatment and prevention<br />
Zentrum für Infektiologie<br />
Abteilung Molekulare Virologie<br />
UniversitätsKlinikum Heidelberg<br />
Thursday, 20 October 2016<br />
5:15 pm – 6:00 pm<br />
Hall 1 – 2. Floor<br />
Junior Investigator Award of the European Society of Virology<br />
Dr. Vincent J. Munster<br />
The ecology of emerging viruses: From host reservoir to disease<br />
Virus Ecology Unit<br />
Laboratory of Virology<br />
Rocky Mountain Laboratories, NIAID/NIH<br />
Hamilton MT<br />
Wednesday, 19 October 2016<br />
6:15 pm – 7:00 pm<br />
Hall 1 – 2. Floor<br />
Travel Grant Winners<br />
Congratulations to the winners of a travel grant<br />
of the European Society for Virology:<br />
Maite Baz-Martínez, Santiago De Compostela, Spain<br />
Simon Boudreault, Sherbrooke, Canada<br />
Christiane Anika Bresk, Innsbruck, Austria<br />
Carlos Castaño-Rodriguez, Madrid, Spain<br />
Meiling Dai, Utrecht, Netherlands<br />
Sandra Dehn, Tübingen, Germany<br />
Alexandra Dudek, Freiburg, Germany<br />
Sebastien Felt, Charlotte, USA<br />
Ana Rita Ferreira, Aveiro, Portugal<br />
Wilhelm Furnon, Lyon, France<br />
Nicole Grandi, Monserrato, Italy<br />
Elena Moreno del Olmo, Madrid, Spain<br />
Ahmed Mesalam, Ghent, Belgium<br />
Dominik Schmiedel, Jerusalem, Israel<br />
Mathieu Sikorski, Nantes, France<br />
Julie Tai, Jerusalem, Israel<br />
Su Hui Catherine Teo, London, UK<br />
Kirstin Vonderstein, Umeå, Sweden<br />
Yury Zhernov, Moscow, Russia<br />
Congratulations to the winners of a travel grant<br />
of the European Society for Veterinary Virology:<br />
Fanny Bringolf, Bern, Switzerland<br />
Sabri Hacioglu, Ankara, Turkey<br />
Vincent Legros, Paris, France<br />
13
14<br />
6 th<br />
European Congress of Virology
General Information<br />
Congress Venue<br />
CCH Congress Center Hamburg<br />
Am Dammtor / Marseiller Strasse<br />
20355 Hamburg<br />
Germany<br />
Opening Hours Registration<br />
Wednesday, 19.10.2016: 11:30 – 19:30<br />
Thursday, 20.10.2016: 07:30 – 18:30<br />
Friday, 21.10.2016: 07:30 – 19:00<br />
Saturday, 22.10.2016: 07:30 – 19:00<br />
Opening Hours Exhibition<br />
Wednesday, 19.10.2016: 12:30 – 18:00<br />
Thursday, 20.10.2016: 09:30 – 17:30<br />
Friday, 21.10.2016: 09:30 – 17:00<br />
Saturday, 22.10.2016: 09:30 – 15:00<br />
Accreditation<br />
CME accredited: 33 points<br />
Recognition of Tierärztekammer Hamburg (vet board) applied.<br />
Posters<br />
Scientific posters will be presented in the following topic groups:<br />
Basic Virology: Foyer Hall D-G<br />
Zonooses, Emerging Infections: Hall D+E<br />
Clinical Virology: Hall E<br />
Immunity: Hall E<br />
There will be Poster Sessions at the poster areas as follows:<br />
Wednesday, 19 October: 18:00 – 20:00<br />
Thursday, 20 October: 17:30 – 19:30<br />
Friday, 21 October: 17:15 – 19:00<br />
See page 31ff for details.<br />
WiFi<br />
WiFi is available at the congress.<br />
WLAN network:<br />
_WIFI_SMS-CCH<br />
Password:<br />
wifi2016cch<br />
You need to enter your country and your mobile phone number and will get a password via SMS which<br />
is valid for that day.<br />
The detailed programme is subject to change.<br />
15
6 th<br />
European Congress of Virology<br />
<strong>Programme</strong> Overview<br />
Wednesday, 19t h October<br />
Hall 1 – 2. Floor Hall F – 2. Floor Hall A – 1. Floor Hall B – 1. Floor<br />
13:00 Welcome<br />
14:00<br />
15:00<br />
PS1<br />
The Future of Antiviral<br />
Therapy<br />
16:00<br />
17:00<br />
WS1<br />
Innate Antiviral Immunity<br />
and Viral Immune Evasion<br />
Coffee Break + Visit Industry Exhibition<br />
WS2<br />
Restriction Factors of Viral<br />
Infection<br />
WS3<br />
Virus Attachment and<br />
Entry<br />
WS4<br />
Virus Replication Strategies<br />
18:00 18:15 – 19:00<br />
ESV Junior<br />
19:00<br />
Investigator Award<br />
Poster Exhibition<br />
Poster Session<br />
16
Thursday, 20 th October<br />
Hall 1 – 2. Floor Hall F – 2. Floor Hall A – 1. Floor Hall B – 1. Floor<br />
08:00<br />
09:00<br />
10:00<br />
WS5<br />
Adaptive Antiviral Immunity<br />
and Viral Immune<br />
Evasion<br />
WS6<br />
Virus Maturation and<br />
Egress<br />
WS7<br />
Advanced Virus Diagnosis<br />
WS8<br />
Viral Pathogenesis<br />
Coffee Break + Visit Industry Exhibition<br />
11:00<br />
12:00<br />
PS2<br />
Animal Models for Virus<br />
Research<br />
13:00<br />
14:00<br />
Lunch Break<br />
Symposium: Novel Technologies<br />
for Improved<br />
Pathogen Detection<br />
Lunch Break / Visit Industry Exhibition<br />
15:00<br />
16:00<br />
WS9<br />
Humoral Immune<br />
Response to Viral Infection<br />
WS10<br />
Virus Structure and Imaging<br />
WS11<br />
Approved Anti viral Therapies<br />
WS12<br />
Pediatric Viral Infections<br />
17:00 17:15 – 19:00<br />
EVA - European Virology<br />
Award<br />
18:00<br />
Investigator Award<br />
19:00<br />
Poster Exhibition<br />
Poster Session<br />
17
6 th<br />
European Congress of Virology<br />
<strong>Programme</strong> Overview<br />
Friday, 21 st October<br />
Hall 1 – 2. Floor Hall F – 2. Floor Hall A – 1. Floor Hall B – 1. Floor<br />
08:00<br />
09:00<br />
10:00<br />
WS13<br />
Antiviral<br />
Vaccines<br />
WS14<br />
Emerging Topics in Veterinary<br />
Virology<br />
WS15<br />
Oncogenic Mechanisms of<br />
Viruses<br />
WS16<br />
Viral Latency and Persistence<br />
11:00 PS3<br />
Emerging<br />
12:00<br />
Virus Infections<br />
13:00<br />
14:00<br />
15:00<br />
16:00<br />
Lunch Break<br />
WS17<br />
Experimental Antiviral<br />
Therapies<br />
Coffee Break + Visit Industry Exhibition<br />
Symposium:<br />
HBV and HIV Cure<br />
WS18<br />
Highly Pathogenic Viruses<br />
Lunch Break / Visit Industry Exhibition<br />
WS19<br />
Viral Gene Expression –<br />
Transcription, Translation<br />
WS20<br />
Viral Vectors for Vaccine<br />
Design<br />
17:00 General<br />
18:00 Assembly - ESV<br />
19:00<br />
20:00<br />
21:00<br />
22:00<br />
23:00<br />
Congress Dinner & Networking Event<br />
Poster Exhibition<br />
Poster Session<br />
18
Saturday, 22 nd October<br />
Hall 1 – 2. Floor Hall F – 2. Floor Hall A – 1. Floor Hall B – 1. Floor<br />
08:00<br />
09:00 WS21<br />
Viral Evolution and Resistance<br />
10:00<br />
11:00 PS4<br />
12:00 Next Generation Viromics<br />
13:00<br />
14:00<br />
Lunch Break<br />
WS22<br />
Virus Epidemiology and<br />
Surveillance<br />
Symposium: Challenges<br />
in Clinical Virology<br />
WS23<br />
Infection of the Immunocompromised<br />
Coffee Break + Visit Industry Exhibition<br />
Symposium: Emerging<br />
Zoonoses<br />
WS24<br />
Zoonotic Viruses<br />
15:00<br />
16:00<br />
WS25<br />
Curative Strategies for<br />
Virus Eradication<br />
WS26<br />
Virus Discovery, Typing<br />
and Metagenomics<br />
WS27<br />
Vector Borne Infections<br />
WS28<br />
Best of Posters<br />
17:00 Farewell<br />
19
6 th<br />
European Congress of Virology<br />
Detailed <strong>Programme</strong><br />
Wednesday, 19 th October<br />
13:30 – 15:30<br />
16:00 – 18:00<br />
16:00 – 18:00<br />
Plenary Session 1:<br />
The Future of<br />
Antiviral Therapy<br />
WS1:<br />
Innate Antiviral<br />
Immunity and<br />
Viral Immune<br />
Evasion<br />
WS2:<br />
Restriction<br />
Factors of Viral<br />
Infection<br />
13:00 – 13:30 Opening Ceremony – Welcome Session Hall 1 - 2.Floor<br />
Chairpersons Klaus Überla, Erlangen, Germany<br />
Olaf Degen, Hamburg, Germany<br />
13:30 – 14:00 Antiviral drug development: Assessing the present, imagining the future<br />
Don Ganem, Emeryville CA, USA<br />
14:00 – 14:30 Strategies to manage herpesvirus drug-resistance<br />
Graciela Andrei, Leuven, Belgium<br />
14:30 – 15:00 Entry inhibition as a future therapeutic option to treat hepatitis B and<br />
hepatitis D virus infection<br />
Stephan Urban, Heidelberg, Germany<br />
15:00 – 15:30 Long-acting injectables for HIV therapy and prevention<br />
Paul Benn, London, UK<br />
15:30 – 16:00 Coffee Break Foyer D-G; Hall G, D and E - 2.Floor<br />
Chairpersons Marcus Altfeld, Hamburg, Germany<br />
Teunis B. Geijtenbeek, Amsterdam, The Netherlands<br />
16:00 – 16:30 Keynote: How viruses usurp the host cellular machineries to evade innate<br />
immune responses: The case of the restriction factor BST2/Tetherin and the<br />
HIV-1 protein Vpu<br />
Clarisse Berlioz-Torrent, Paris, France<br />
16:30 – 17:00 Keynote: HIV-1 evades innate sensing by a novel RNA sensor in dendritic<br />
cells<br />
Teunis B.H. Geijtenbeek, Amsterdam, The Netherlands<br />
17:00 – 17:15 Cytomegalovirus recruits the retromer complex to promote NEMO degradation<br />
by autophagy<br />
Elena Muscolino, Hamburg, Germany<br />
17:15 – 17:30 Human herpesvirus 6 downregulates the expression of activating ligands<br />
during lytic infection to escape elimination by natural killer cells<br />
Dominik Schmiedel, Jerusalem, Israel<br />
17:30 – 17:45 Antiviral activity of the cGAS-STING pathway against hepatitis B virus<br />
i nfection<br />
Seung-Ae Yim, Strasbourg, France<br />
17:45 – 18:00 Membranous fingerprinting of HIV-1 infected primary CD4+ T cells reveals<br />
virus-mediated dysregulation of a putative NK cell receptor<br />
Sandra Dehn, Tübingen, Germany<br />
Chairpersons Michael H. Malim, London, UK<br />
Julian Schulze zur Wiesch, Hamburg, Germany<br />
16:00 – 16:30 Keynote: HIV restriction - striking early<br />
Michael H. Malim, London, UK<br />
16:30 – 16:45 Requirements for initiation factors in the translation of hepatitis C virus<br />
Esther Gonzalez-Almela, Madrid, Spain<br />
16:45 – 17:00 Identification of potent restriction factors of hepatitis C virus infection and<br />
their contribution to viral species-tropism<br />
Richard J. P. Brown, Hannover, Germany<br />
17:00 – 17:15 Novel techniques for genome visualization reveal the fate of incoming<br />
adenoviral genomes against nuclear antiviral factors<br />
Tetsuro Komatsu, Bordeaux, France<br />
17:15 – 17:30 The antiviral protein viperin targets tick-borne encephalitis virus replication<br />
and assembly<br />
Kirstin Vonderstein, Umeå, Sweden<br />
17:30 – 17:45 In vivo evasion of MxA reveals pandemic potential of emerging influenza A<br />
viruses<br />
Ebrahim Hassan, Freiburg, Germany<br />
17:45 – 18:00 SMARCA2 the ATPase subunit of the chromatin remodeling BAF complex is<br />
required for the antiviral activity of MxA<br />
Alexandra Dudek, Freiburg, Germany<br />
Hall 1 – 2. Floor<br />
Hall 1 – 2. Floor<br />
Hall F – 2. Floor<br />
20
Wednesday, 19 th October<br />
16:00 – 18:00<br />
16:00 – 18:00<br />
WS3:<br />
Virus Attachment<br />
and Entry<br />
WS4:<br />
Virus Replication<br />
Strategies<br />
Chairpersons Dimitri Lavillette, Shanghai, China<br />
Urs Greber, Zurich, Switzerland<br />
16:00 – 16:30 Keynote: Insights into principles of virus entry and uncoating<br />
Urs Greber, Zurich, Switzerland<br />
16:30 – 16:45 Native structure of a retroviral envelope protein and its conformational<br />
change upon interaction with the target cell<br />
Christiane Riedel, Vienna, Austria<br />
16:45 – 17:00 Quantitative phospho-proteomics reveal new insights into signaling events<br />
triggered by influenza A virus infection<br />
Silke Stertz, Zurich, Switzerland<br />
17:00 – 17:15 The cytoskeletal adaptor protein obscurin-like 1 interacts with L2 and is<br />
required for HPV16 endocytosis<br />
Elena Wüstenhagen, Mainz, Germany<br />
17:15 – 17:30 The spike protein of the middle east respiratory syndrome coronavirus has<br />
sialic acid binding activity<br />
Ivy Widjaja, Utrecht, The Netherlands<br />
17:30 – 17:45 Quantification of the binding forces of Dengue virus with cell receptors at a<br />
single-virus level<br />
Yueh-Hsin Ping, Taiwan, Republic of China<br />
17:45 – 18:00 Switching to LAMP1 during cell entry of Lassa virus<br />
Ron Diskin, Rehovot, Israel<br />
Chairpersons Gabriella Campadelli-Fiume, Bologna, Italy<br />
Vincent Parissi, Bordeaux, France<br />
16:00 – 16:30 Keynote: Control of, and regulation by, the BKPyV miRNA<br />
Michael J. Imperiale, Ann Arbor MI, USA<br />
16:30 – 16:45 An enterovirus mutant that can replicate in the absence of replication<br />
organelles<br />
Frank van Kuppeveld, Utrecht, The Netherlands<br />
16:45 – 17:00 Chikungunya trans-replication systems as tools to study the properties of<br />
replicase proteins<br />
Tania Quirin, Helsinki, Finland<br />
17:00 – 17:15 Delineating the interplay between the PB2 protein of influenza A virus and<br />
the host ubiquitin proteasome system<br />
Elise Biquand, Paris, France<br />
17:15 – 17:30 Is replication fidelity of influenza A viruses modulated by a proofreading<br />
activity?<br />
Marion Declercq, Paris, France<br />
17:30 – 17:45 Single-molecule FISH reveals non-selective packaging of Rift Valley fever<br />
virus genome segments<br />
Paul Wichgers Schreur, Lelystad, The Netherlands<br />
17:45 – 18:00 Usp7, an ubiquitin specific protease, interacts with Merkel Cell polyomavirus<br />
large T-antigen and modulates viral DNA replication<br />
Manja Czech-Sioli, Hamburg, Germany<br />
Hall A – 1. Floor<br />
Hall B – 1. Floor<br />
18:15 – 19:00 ESV Junior Investigator Award<br />
Hall 1 –<br />
2. Floor<br />
18:00 – 20:00 Poster Session – Scientific Networking<br />
21
6 th<br />
European Congress of Virology<br />
Detailed <strong>Programme</strong><br />
Thursday, 20 th October<br />
08:30 – 10:30<br />
08:30 – 10:30<br />
08:30 – 10:30<br />
WS5:<br />
Adaptive Antiviral<br />
Immunity and<br />
Viral Immune<br />
Evasion<br />
WS6:<br />
Virus Maturation<br />
and Egress<br />
WS7:<br />
Advanced Virus<br />
Diagnosis<br />
Chairpersons Thomas Harrer, Erlangen, Germany<br />
Julian Schulze zur Wiesch, Hamburg, Germany<br />
08:30 – 09:00 Keynote: Mechanisms of HIV pathogenesis and HIV cure – insights from the<br />
paediatric HIV infection<br />
Philip Goulder, Oxford, UK<br />
09:00 – 09:15 Protein carbamoylation increases the restimulation of pp65-specific T cells in<br />
vitro<br />
Ralf Wagner, Regensburg, Germany<br />
09:15 – 09:30 Specificity and phenotype of T cells in primary human cytomegalovirus<br />
infection in pregnancy<br />
Daniele Lilleri, Pavia, Italy<br />
09:30 – 09:45 Sequence-function analysis of three T-cell receptors targeting the HIV-1 p17<br />
epitope SLYNTVATL<br />
Thomas Harrer, Erlangen, Germany<br />
09:45 – 10:00 An immune-competent inbred mouse model of HCV-related rodent hepacivirus<br />
infection<br />
Eva Billerbeck, New York City NY, USA<br />
10:00 – 10:15 Identification of novel MHC I and MHC II restricted hepatitis D virus-specific<br />
peptide epitopes<br />
Johanna Blöcker, Hamburg, Germany<br />
10:15 – 10:30 Analysis of the adaptive cellular immune response to Nipah virus-like particles<br />
in C57BL/6 and Balb/c mice<br />
Sandra Diederich, Greifswald - Insel Riems, Germany<br />
Chairpersons Hans-Georg Kräusslich, Heidelberg, Germany<br />
Beate Sodeik, Hannover, Germany<br />
08:30 – 09:00 Keynote: Herpesvirus nuclear egress – elucidation of the prototypic vesicular<br />
nucleo-cytoplasmic transport<br />
Thomas Mettenleiter, Greifswald – Insel Riems, Germany<br />
09:00 – 09:30 Keynote: Host-catalyzed capsid assembly modulation: A new approach to<br />
anti-viral drug discovery<br />
Vishwanath R. Lingappa, San Francisco CA, USA<br />
09:30 – 09:45 A secretory pathway calcium ATPase regulates viral spread by modulating<br />
cellular proteolysis<br />
Hans-Heinrich Hoffmann, New York City NY, USA<br />
09:45 – 10:00 Incorporation of the influenza A virus NA segment does not require homologous<br />
non-coding sequences<br />
Sylvie van der Werf, Paris, France<br />
10:00 – 10:15 Proteomics of HCV virions reveals a surprising role for the nucleoporin<br />
Nup98 in virus morphogenesis<br />
Maria Teresa Catanese, London, UK<br />
10:15 – 10:30 Role of Rab33B and its autophagic Atg5/12/16L1 effector in hepatitis B virus<br />
morphogenesis<br />
Christina Bartusch, Mainz, Germany<br />
Chairpersons Elisabeth Puchhammer, Vienna, Austria<br />
René A.A. van der Vlugt, Wageningen, The Netherlands<br />
08:30 – 09:00 Keynote: Prospects for digital PCR in viral diagnostics<br />
Ward De Spiegelaere, Ghent, Belgium<br />
09:00 – 09:15 Infectious Laryngotracheitis virus (ILTV) vaccine intake evaluation by detection<br />
of virus amplification in feather pulps of vaccinated chickens<br />
Irit Davidson, Bet Dagan, Israel<br />
09:15 – 09:30 Influence of glycoprotein C on Bovine Herpesvirus-1 virion composition and<br />
implications for diagnostics<br />
Susanne Koethe, Greifswald - Insel Riems, Germany<br />
09:30 – 09:45 The immunoglobulin-like domain of HsFcµR (TOSO, FAIM3) binds IgM/<br />
antigen immune complexes and can be used as a novel capture molecule in<br />
serological tests<br />
Christina Deschermeier, Hamburg, Germany<br />
Hall 1 – 2. Floor<br />
Hall F – 2. Floor<br />
Hall A – 1. Floor<br />
22
Thursday, 20 th October<br />
08:30 – 10:30<br />
11:00 – 13:00<br />
WS7:<br />
Advanced Virus<br />
Diagnosis<br />
WS8:<br />
Viral Pathogenesis<br />
Plenary Session 2:<br />
Animal Models<br />
for Virus Research<br />
09:45 – 10:00 Development of ELISA for detection of Seneca Valley virus exposure<br />
Zeynep Akkutay-Yoldar, Ankara, Turkey<br />
10:00 – 10:15 NS1-based anti-Zika virus ELISA revealed no cross-reactivity with other flavivirus<br />
infections or vaccination<br />
Katja Steinhagen, Lübeck, Germany<br />
10:15 – 10:30 Clinical evaluation of the Veris HCV assay for hepatitis C virus RNA quantification<br />
Laure Izquierdo, Villejuif, France<br />
Chairpersons Giorgio Palù, Padova, Italy<br />
Maria G. Masucci, Stockholm, Sweden<br />
08:30 – 09:00 Keynote: Viral interference with ubiquitin and UbL-regulated signaling<br />
pathways<br />
Maria G. Masucci, Stockholm, Sweden<br />
09:00 – 09:15 Th17, CCR6+ cells lack RNAses and are highly permissive to HIV infection:<br />
Implications for pathogenesis and therapy<br />
Alfredo Garzino Demo, Padova, Italy<br />
09:15 – 09:30 Bio-imaging of alphaviral disease in mice: A study using Ross River virus<br />
Essia Belarbi, Fontenay aux Roses, France<br />
09:30 – 09:45 Comparative analysis between flaviviruses reveals specific neural stem cell<br />
tropism for Zika virus in the mouse developing neocortex<br />
Cecile Khou, Paris, France<br />
09:45 – 10:00 Susceptibility and inflammatory response of human neural cells to Zika virus<br />
and West Nile virus infection<br />
Giovanna Desole, Padova, Italy<br />
10:00 – 10:15 Transcriptome analysis of human fetal astrocytes infected with Zika virus<br />
reveals dysregulation of genes required for brain development<br />
Daniel Limonta, Edmonton, Canada<br />
10:15 – 10:30 Pathogenesis of Zika virus infection in a non-human primate model<br />
Patricia Pesavento, Davis CA, USA<br />
10:30 – 11:00 Coffee Break Foyer D-G; Hall G, D and E - 2.Floor<br />
Chairpersons Marc Lütgehetmann, Hamburg, Germany<br />
Cesar Muñ oz-Fontela, Hamburg, Germany<br />
11:00 – 11:30 Animal models to assess efficacy of infectious disease intervention:<br />
Ebola, CCHR and Influenza<br />
Miles W. Carroll, Salisbury, UK<br />
11:30 – 12:00 Human tumor virus infection and immune control in vivo<br />
Christian Münz, Zurich, Switzerland<br />
12:00 – 12:30 Animal models of viral hepatitis<br />
Alexander Ploss, Princeton NJ, USA<br />
12:30 – 13:00 Humanized mouse models for the study of viral pathogens and persistence<br />
J. Victor Garcia, Chapel Hill NC, USA<br />
13:00 – 15:00 Lunch Break Foyer D-G; Hall G, D and E - 2.Floor<br />
Hall A – 1. Floor<br />
Hall B – 1. Floor<br />
Hall 1 – 2. Floor<br />
Satellite<br />
Symposium<br />
13:15 – 14:15<br />
QIAGEN-Symposium:<br />
“Novel Technologies for Improved Pathogen Detection“<br />
Hall F –<br />
2. Floor<br />
23
6 th<br />
European Congress of Virology<br />
Detailed <strong>Programme</strong><br />
Thursday, 20 th October<br />
15:00 – 17:00<br />
15:00 – 17:00<br />
15:00 – 16:30<br />
WS9:<br />
Humoral Immune<br />
Response to Viral<br />
Infection<br />
WS10:<br />
Virus Structure<br />
and Imaging<br />
WS11:<br />
Approved Antiviral<br />
Therapies<br />
Chairpersons Florian Klein, Cologne, Germany<br />
Alexandra Trkola, Zurich, Switzerland<br />
15:00 – 15:30 Keynote: Virus, host and disease factors govern HIV-1 broadly neutralizing<br />
antibody induction<br />
Alexandra Trkola, Zurich, Switzerland<br />
15:30 – 15:45 Long-term immunogenicity of bivalent and quadrivalent human papillomavirus<br />
vaccines in the target population of organized vaccination programs<br />
Luisa Barzon, Padova, Italy<br />
15:45 – 16:00 Association of human IgG1 heavy chain variants on neutralization capacity<br />
and antibody dependent cellular cytotoxicity against HCMV<br />
Hannes Vietzen, Vienna, Austria<br />
16:00 – 16:15 HIV Env antibody can provide sterilizing immunity in the strictest sense<br />
Klaus Überla, Erlangen, Germany<br />
16:15 – 16:30 Hemagglutinin-stem nanoparticles generate heterosubtypic influenza<br />
protection<br />
Hadi Yassine, Doha, Qatar<br />
16:30 – 16:45 Structural basis of Zika virus cross-reactivity and cross-neutralization with<br />
flavivirus post-infection and post-vaccination sera<br />
Karin Stiasny, Vienna, Austria<br />
16:45 – 17:00 Experimental infection of horses with nonprimate hepacivirus mediates<br />
immune protection against re-infection<br />
Stephanie Pfänder, Hannover, Germany<br />
Chairpersons Félix A. Rey, Paris, France<br />
Kay Grünewald, Hamburg, Germany<br />
15:00 – 15:30 Keynote: The structurally identified homology between viral and cellular<br />
membrane fusion proteins highlights the impact of genetic exchanges<br />
during evolution<br />
Félix A. Rey, Paris, France<br />
15:30 – 15:45 Flying viruses – from biophysical to structural characterisation<br />
Charlotte Uetrecht, Hamburg, Germany<br />
15:45 – 16:00 Live cell dynamics of herpesvirus nuclear egress<br />
Jens Bosse, Hamburg, Germany<br />
16:00 – 16:15 Cellular microtubule scaffold promotes efficient assembly and genome<br />
packaging of the non-enveloped virus reovirus<br />
Pranav Shah, Heidelberg, Germany<br />
16:15 – 16:30 Aggregates or virus-like particles? Ordered structure of isolated matrix<br />
protein M1 revealed by SAXS and AFM<br />
Eleonora Shtykova, Moscow, Russian Federation<br />
16:30 – 16:45 Acidic pH-induced conformation and LAMP1 inding of the lassa virus glycoprotein<br />
spike<br />
Sai Li, Oxford, UK<br />
16:45 – 17:00 Nucleic acid binding motif in capsid protein of Mason-Pfizer monkey virus<br />
Pavel Ulbrich, Prague, Czech Republic<br />
Chairpersons Hans-Jürgen Stellbrink, Hamburg, Germany<br />
Jürgen Rockstroh, Bonn, Germany<br />
15:00 – 15:30 Keynote: Approved antivirals for HIV, HBV and HCV:<br />
What has been achieved, what are the remaining challenges?<br />
Jürgen Rockstroh, Bonn, Germany<br />
15:30 – 16:00 Keynote: Presence and future of HEV treatment options<br />
Sven Pischke, Hamburg, Germany<br />
16:00 – 16:15 Acute hepatitis E in patients with gynecological malignancy – a case series<br />
Stefan Schlabe, Bonn, Germany<br />
16:15 – 16:30 In silico evaluation of Oseltamivir treatment strategies against Influenza –<br />
Pneumococcus coinfection<br />
Alessandro Boianelli, Braunschweig, Germany<br />
Hall 1 – 2. Floor<br />
Hall F – 2. Floor<br />
Hall A – 1. Floor<br />
24
Thursday, 20 th October<br />
15:00 – 17:00<br />
WS12:<br />
Pediatric Viral<br />
Infections<br />
Chairpersons Dana Wolf, Jerusalem, Israel<br />
Annette Haberl, Frankfurt, Germany<br />
15:00 – 15:30 Keynote: Congenital human cytomegalovirus transmission and pathogenesis:<br />
From epidemiology to experimental modeling<br />
Dana Wolf, Jerusalem, Israel<br />
15:30 – 15:45 Differential diagnosis of respiratory and enteric viral infections in children<br />
Aleksandra Nikonova, Moscow, Russian Federation<br />
15:45 – 16:00 Discovery of a potent, M2-1-targeting inhibitor of human respiratory syncytial<br />
virus infection in vivo<br />
Benjamin Bailly, Gold Coast, Australia<br />
16:00 – 16:15 Repurposing suramin and zanamivir into a synergistic combination that<br />
blocks human parainfluenza type-3 virus infection<br />
Benjamin Bailly, Gold Coast, Australia<br />
16:15 – 16:30 Vaccine effectiveness and genetic diversity in the context of increasing<br />
immunization rates against Rotavirus infections<br />
Corinna Pietsch, Leipzig, Germany<br />
16:30 – 16:45 Universal neonatal Cytomegalovirus screening using saliva:<br />
Report of an experience in an Italian center<br />
Simona Fiorentini, Brescia, Italy<br />
16:45 – 17:00 Development of a murine model of Enterovirus 71 (EV71) infection, disease,<br />
and pathology using mouse-cell-adapted strains<br />
Carla B. L. Victorio, Singapore, Singapore<br />
Hall B – 1. Floor<br />
17:15 – 18:00 EVA – European Virology Award<br />
Hall 1 –<br />
2. Floor<br />
17:30 – 19:30 Poster Session – Scientific Networking<br />
from 18:30<br />
ESV – Executive Board and Advisory Council Meeting<br />
Hall C –<br />
1. Floor<br />
25
6 th<br />
European Congress of Virology<br />
Detailed <strong>Programme</strong><br />
Friday, 21 st October<br />
08:30 – 10:30<br />
08:30 – 10:30<br />
08:30 – 10:30<br />
WS13:<br />
Antiviral Vaccines<br />
WS14:<br />
Emerging Topics<br />
in Veterinary<br />
Virology<br />
WS15:<br />
Oncogenic<br />
Mechanisms of<br />
Viruses<br />
Chairpersons Ralf Wagner, Regensburg, Germany<br />
Giuseppe Pantaleo, Lausanne, Switzerland<br />
08:30 – 09:00 Keynote: HIV vaccine: Myth or reality?<br />
Giuseppe Pantaleo, Lausanne, Switzerland<br />
09:00 – 09:15 rVSV-platform: Immunogenicity data against the vector and insert of rVSV-<br />
ZEBOV in healthy adults – a phase I study<br />
Christine Dahlke, Hamburg, Germany<br />
09:15 – 09:30 Vaccine generation against gamma herpesvirus infection in a murine<br />
surrogate model<br />
Baila Samreen, Düsseldorf, Germany<br />
09:30 – 09:45 Efficient immunization and full protection from lethal challenge by DNA-YF-<br />
Vax, a novel thermostable and readily scalable plasmid-launched live-attenuated<br />
yellow fever vaccine candidate produced in E. coli<br />
Kai Dallmeier, Leuven, Belgium<br />
09:45 – 10:00 Triterpen saponins of plant origin incorporated into saponin/lipid nanoparticles<br />
as an efficient adjuvant system for mucosal immunization<br />
Vladimir Berezin, Almaty, Kazakhstan<br />
10:00 – 10:15 Modified vaccinia virus based vaccine protection against MERS-CoV<br />
in fection in dromedary camels<br />
V. Stalin Raj, Rotterdam, The Netherlands<br />
10:15 – 10:30 Pathogens inactivated by low-energy-electron irradiation maintain antigenic<br />
properties and induce protective immune responses<br />
Jasmin Fertey, Leipzig, Germany<br />
Chairpersons Thomas Mettenleiter, Greifswald – Insel Riems, Germany<br />
Wim H. van der Poel, Wageningen, The Netherlands<br />
08:30 – 09:00 Keynote: Emerging topics at issue in veterinary virology<br />
Wim H. van der Poel, Wageningen, The Netherlands<br />
09:00 – 09:15 Full-genome based molecular characterization of encephalitis-associated<br />
bovine astroviruses<br />
Torsten Seuberlich, Bern, Switzerland<br />
09:15 – 09:30 Newly discovered polyomaviruses in animals: Uncovering causality<br />
Patricia Pesavento, Davis CA, USA<br />
09:30 – 09:45 Macrophages from pigs lacking the SRCR5 domain of CD163 are resistant to<br />
porcine reproductive and respiratory syndrome virus infection<br />
Christine Burkard, Roslin, UK<br />
09:45 – 10:00 Virus-host interactome high-throughput mapping: From the identification of<br />
new factors of pathogenicity and interspecies transmission to new therapeutic<br />
targets for an animal arbovirus<br />
Grégory Caignard, Maisons-Alfort, France<br />
10:00 – 10:15 Immunogenicity and protective efficacy of recombinant Modified Vaccinia<br />
virus Ankara candidate vaccines delivering West Nile virus envelope antigens<br />
vaccine<br />
Asisa Volz, Munich, Germany<br />
10:15 – 10:30 Novel variant of porcine epidemic diarrhea virus in England detected<br />
through archive mining<br />
Falko Steinbach, Addlestone, UK<br />
Chairpersons Thomas Dobner, Hamburg, Germany<br />
Massimo Tommasino, Lyon, France<br />
08:30 – 09:00 Keynote: Novel insights into viral-mediated tumorigenesis<br />
Susanna Chiocca, Milano, Italy<br />
09:00 – 09:30 Keynote: Oncogenic viruses and more: Impact on host pathways and<br />
co operation with environmental factors<br />
Massimo Tommasino, Lyon, France<br />
Hall 1 – 2. Floor<br />
Hall F – 2. Floor<br />
Hall A – 1. Floor<br />
26
Friday, 21 st October<br />
08:30 – 10:30<br />
11:00 – 13:00<br />
WS15:<br />
Oncogenic<br />
Mechanisms of<br />
Viruses<br />
WS16:<br />
Viral Latency and<br />
Persistence<br />
Plenary Session 3:<br />
Emerging Virus<br />
Infections<br />
09:30 – 09:45 Human papillomavirus oncogenes contribute to acquisition of stem cell<br />
ability in vitro<br />
Katerina Strati, Nicosia, Cyprus<br />
09:45 – 10:00 PTPN14 is a novel degradation target of human papillomavirus E7 oncoprotein<br />
Anita Szalmas, Debrecen, Hungary<br />
10:00 – 10:15 Interaction of the Merkel Cell polyomavirus LT-antigen with host cell<br />
chromatin<br />
Juliane Theiss, Hamburg, Germany<br />
10:15 – 10:30 Establishment of a human adult stem cell model to understand the role of<br />
EBV oncogenic mechanisms in epithelial malignancies<br />
Wilhelm Ching, Hamburg, Germany<br />
Chairpersons Bernhard Fleckenstein, Erlangen, Germany<br />
Carmen Rivas, Madrid, Spain<br />
08:30 – 09:00 Keynote: Targeting of cellular SUMO-regulated pathways by KSHV latent<br />
protein LANA2<br />
Carmen Rivas, Madrid, Spain<br />
09:00 – 09:15 Classical swine fever virus generate superinfection exclusion at the organism<br />
level in swine<br />
Llilianne Ganges, Barcelona, Spain<br />
09:15 – 09:30 Parvovirus B19 persists in tonsillar B cells<br />
Mari Toppinen, Helsinki, Finland<br />
09:30 – 09:45 Humanized mice to study acute and persistent human adenovirus infections<br />
Estefania Rodriguez, Hamburg, Germany<br />
09:45 – 10:00 Generation of human peripheral neurons to study Varicella Zoster virus<br />
latency, reactivation and induction of pain<br />
Abel Viejo-Borbolla, Hannover, Germany<br />
10:00 – 10:15 Analyzing mechanisms of KSHV latency and intervention using novel in vitro<br />
and in vivo models<br />
Tatyana Dubich, Braunschweig, Germany<br />
10:15 – 10:30 BRD2/4-mediated chromatin association of LANA is important for latent<br />
persistence of KSHV<br />
Rishikesh Lotke, Hannover, Germany<br />
10:30 – 11:00 Coffee Break Foyer D-G; Hall G, D and E – 2.Floor<br />
Chairpersons Marylyn M. Addo, Hamburg, Germany<br />
Denis Fargette, Montpellier, France<br />
11:00 – 11:30 Filovirus infections in bats and humans<br />
Jonathan Towner, Atlanta GA, USA<br />
11:30 – 12:00 Emerging viral infections: The power of deep sequencing<br />
Martin Beer, Greifswald - Insel Riems, Germany<br />
12:00 – 12:30 Biogeography of viral emergence: Rice yellow mottle virus as a case study<br />
Denis Fargette, Montpellier, France<br />
12:30 – 13:00 Emerging viruses in the Balkan and Mediterranean region<br />
Anna Papa, Thessaloniki, Greece<br />
13:00 – 15:00 Lunch Break Foyer D-G; Hall G, D and E – 2.Floor<br />
Hall A – 1. Floor<br />
Hall B – 1. Floor<br />
Hall 1 – 2. Floor<br />
Satellite<br />
Symposium<br />
13:15 – 14:45<br />
ANRS / DZIF Symposium:<br />
“HBV and HIV Cure“<br />
Hall F –<br />
2. Floor<br />
27
6 th<br />
European Congress of Virology<br />
Detailed <strong>Programme</strong><br />
Friday, 21 st October<br />
15:00 – 17:00<br />
15:00 – 17:00<br />
15:00 – 17:00<br />
WS17:<br />
Experimental<br />
Antiviral<br />
Therapies<br />
WS18:<br />
Highly Pathogenic<br />
Viruses<br />
WS19:<br />
Viral Gene<br />
Expression –<br />
Transcription,<br />
Translation<br />
Chairpersons Ben Berkhout, Amsterdam, The Netherlands<br />
Ralf Bartenschlager, Heidelberg, Germany<br />
15:00 – 15:30 Keynote: From oncolytic virotherapy to oncolytic immunotherapy<br />
Gabriella Campadelli-Fiume, Bologna, Italy<br />
15:30 – 16:00 Keynote: Antiviral therapy of chronic hepatitis C: Remaining challenges and<br />
new opportunities<br />
Ralf Bartenschlager, Heidelberg, Germany<br />
16:00 – 16:15 Polo-like-kinase 1 is a proviral host-factor for hepatitis B virus replication and<br />
a target for combined antiviral strategies<br />
David Durantel, Lyon, France<br />
16:15 – 16:30 Characterization of a novel human monoclonal antibody targeting the<br />
hepatitis C virus envelope protein<br />
Ahmed Atef Mesalam, Ghent, Belgium<br />
16:30 – 16:45 Humanization of a claudin-1-specific monoclonal antibody to prevent and<br />
cure HCV infection without escape<br />
Che C. Colpitts, Strasbourg, France<br />
16:45 – 17:00 A phase 1, open label, dose-escalation study of the safety, pharmacokinetics<br />
and antiretroviral activity of 10-1074 monoclonal antibody in HIV-infected<br />
and HIV-uninfected individuals<br />
Till Schoofs, New York City NY, USA<br />
Chairpersons Stefan Günther, Hamburg, Germany<br />
Heinz Feldmann, Hamilton MT, USA<br />
15:00 – 15:30 Keynote: Vaccine approaches for highly pathogenic viruses<br />
Heinz Feldmann, Hamilton MT, USA<br />
15:30 – 15:45 Interference of MERS-CoV accessory genes with the innate immune<br />
re sponse and their contribution to virulence<br />
Isabel Sola, Madrid, Spain<br />
15:45 – 16:00 Role of SARS-CoV viroporins E, 3a, and 8a in virus replication and virulence:<br />
Complementation between the PBMs of E and 3a proteins<br />
Carlos Castaño-Rodríguez, Madrid, Spain<br />
16:00 – 16:15 Immune markers of fatal human Ebola virus disease<br />
Paula Ruibal, Hamburg, Germany<br />
16:15 – 16:30 Regulation of Ebola virus matrix protein VP40 by SUMO<br />
Maite Baz-Martínez, Santiago de Compostela, Spain<br />
16:30 – 16:45 Efficacy of Favipiravir and Ribavirin in a novel mouse model of Lassa fever<br />
Lisa Oestereich, Hamburg, Germany<br />
16:45 – 17:00 HPAIV H5 evolution requires adaptation of the hemagglutinin by elevation of<br />
the fusion competence activation pH<br />
Jürgen Stech, Greifswald – Insel Riems, Germany<br />
Chairpersons Wolfram Brune, Hamburg, Germany<br />
Bryan R. Cullen, Durham NC, USA<br />
15:00 – 15:30 Keynote: Post-transcriptional regulation of viral gene expression<br />
Bryan R. Cullen, Durham NC, USA<br />
15:30 – 15:45 A broad RNA virus survey identifies the miR-17 family as a critical host factor<br />
for pestiviruses<br />
Troels K. H. Scheel, Copenhagen, Denmark<br />
15:45 – 16:00 An unprecedented protein-stimulated -2/-1 ribosomal frameshift mechanism<br />
in arteriviruses<br />
Eric Snijder, Leiden, The Netherlands<br />
16:00 – 16:15 A systematic view on influenza induced host shut-off<br />
Julie Tai, Rehovot, Israel<br />
16:15 – 16:30 Novel preferences in influenza A virus cap-snatching<br />
Zuleyma Peralta, New York City NY, USA<br />
16:30 – 16:45 Spatiotemporal analysis of global protein synthesis and PML domains<br />
asso ciation during HSV infection revealed by click chemistry<br />
Su Hui Catherine Teo, London, UK<br />
16:45 – 17:00 Cardiotonic steroids suppress adenovirus replication<br />
Martha Brown, Toronto, Canada<br />
Hall 1 – 2. Floor<br />
Hall F – 2. Floor<br />
Hall A – 1. Floor<br />
28
Friday, 21 st October<br />
15:00 – 17:00<br />
WS20:<br />
Viral Vectors for<br />
Vaccine Design<br />
Chairpersons Gerd Sutter, Munich, Germany<br />
Peter Liljeström, Stockholm, Sweden<br />
15:00 – 15:30 Keynote: RNA replicon vaccines<br />
Peter Liljeström, Stockholm, Sweden<br />
15:30 – 15:45 Development of MVA-MERS-S for phase I clinical evaluation:<br />
A candidate vaccine against Middle East Respiratory Syndrome coronavirus<br />
Asisa Volz, Munich, Germany<br />
15:45 – 16:00 Clonal Oka varicella vaccine variants with reduced viral genome size and<br />
presumed higher clinical safety<br />
Husam Taher, Kiel, Germany<br />
16:00 – 16:15 Development of an artificial reassortant of Infectious Salmon Anaemia Virus<br />
(ISAV) with reverse genetic system: The solution for a new vaccine against<br />
uncultivable HPR0 genotype strains<br />
Marcelo Cortez-San Martín, Santiago de Chile, Chile<br />
16:15 – 16:30 The viral vector vaccine VSV-GP as vaccine platform<br />
C. Anika Bresk, Innsbruck, Austria<br />
16:30 – 16:45 Priming with a potent HIV-1 DNA vaccine frames the quality of T cell and<br />
antibody responses prior to a poxvirus and protein boost<br />
Benedikt Asbach, Regensburg, Germany<br />
16:45 – 17:00 Integrative approaches towards the generation of a synthetic polio vaccine<br />
Mohammad W. Bahar, Oxford, UK<br />
Hall B - 1. Floor<br />
17:15 – 19:00 General Assembly – ESV<br />
Hall 1 –<br />
2. Floor<br />
17:15 – 19:00 Poster Session – Scientific Networking<br />
19:00 – 00:00 Congress Dinner & Networking Event<br />
Hall 3 –<br />
Ground<br />
Floor<br />
29
6 th<br />
European Congress of Virology<br />
Detailed <strong>Programme</strong><br />
Saturday, 22 nd October<br />
08:30 – 10:30<br />
08:30 – 10:30<br />
08:30 – 10:30<br />
WS21:<br />
Viral Evolution<br />
and Resistance<br />
WS22:<br />
Virus Epidemiology<br />
and Surveillance<br />
WS23:<br />
Infection of the<br />
Immunocompromised<br />
Chairpersons Todd Allen, Cambridge MA, USA<br />
Rolf Kaiser, Cologne, Germany<br />
08:30 – 09:00 Keynote: HIV resistance testing from 1999 to 2016 and beyond<br />
Rolf Kaiser, Cologne, Germany<br />
09:00 – 09:15 Characterisation of longitudinal human cytomegalovirus genome diversity by<br />
next generation sequencing of blood samples from immunocompromised<br />
patients suggests turnover of viral strains<br />
Elias Hage, Hannover, Germany<br />
09:15 – 09:30 PatchDetection: Inference of (seasonally) reoccurring patterns of patches<br />
under positive selection in human influenza A/H3N2 viruses<br />
Thorsten R. Klingen, Braunschweig, Germany<br />
09:30 – 09:45 Differences among mumps virus surface proteins between genotype G and<br />
other genotypes at sites important for immunity and pathogenesis<br />
Tessa Vermeire, Ukkel, Belgium<br />
09:45 – 10:00 Use of Ebola pseudoviruses to interrogate the impact of Ebolavirus<br />
gly coprotein evolution during the West African outbreak<br />
Richard A. Urbanowicz, Nottingham, UK<br />
10:00 – 10:15 Fitness changes and mutation dynamics in evolved hepatitis C virus populations<br />
in the cell culture system<br />
Elena Moreno del Olmo, Madrid, Spain<br />
10:15 – 10:30 Ribavirin-induced mutagenesis of the hepatitis E virus genome in vivo<br />
Daniel Todt, Hannover, Germany<br />
Chairpersons Marion Koopmans, Rotterdam, The Netherlands<br />
Christian Drosten, Bonn, Germany<br />
08:30 – 09:00 Keynote: MERS – a classical zoonosis with a pre-pandemic implication<br />
Christian Drosten, Bonn, Germany<br />
09:00 – 09:15 Seasonality and selective trends in viral acute respiratory tract infections<br />
Patrick Shaw Stewart, Hungerford, UK<br />
09:15 – 09:30 Emergence of highly pathogenic H5Nx influenza A viruses is accompanied<br />
with a change in H5 receptor-binding specificity<br />
Cornelis A.M. de Haan, Utrecht, The Netherlands<br />
09:30 – 09:45 CCHFV in sub saharan africa – Where to find and how to diagnose?<br />
Miriam Andrada Sas, Greifswald - Insel Riems, Germany<br />
09:45 – 10:00 MERS update in Saudi Arabia and probable future outbreaks<br />
Islam Nour, Riyadh, Saudi Arabia<br />
10:00 – 10:15 Epidemiology of the four human coronavirus 229E, HKU1, NL63, and OC43<br />
detected over two years in hospitalized adult patients<br />
Simona Fiorentini, Brescia, Italy<br />
10:15 – 10:30 Targeted enrichment of viral DNA in soft tissues from 300-year-old mummies<br />
from Lithuania<br />
Klaus Hedman, Helsinki, Finland<br />
Chairpersons Thomas Schulz, Hannover, Germany<br />
Hans Hirsch, Basel, Switzerland<br />
08:30 – 09:00 Keynote: Immune responses in replicative and non-replicative virus pathology:<br />
What we can we learn from polyomaviruses<br />
Hans Hirsch, Basel, Switzerland<br />
09:00 – 09:15 The challenges of data robustness in sequencing complete human cytomegalovirus<br />
genomes directly from clinical material<br />
Nicolas Suarez, Glasgow, UK<br />
09:15 – 09:30 Are human myeloid dendritic cells hijacked by the BK polyomavirus?<br />
Mathieu Sikorski, Nantes, France<br />
09:30 – 09:45 Role of neutralizing antibodies in the control of BK polyomavirus reactivation<br />
in kidney transplant recipients<br />
Dorian Mcilroy, Nantes, France<br />
Hall 1 – 2. Floor<br />
Hall F – 2. Floor<br />
Hall A – 1. Floor<br />
30
Saturday, 22 nd October<br />
08:30 – 10:30<br />
11:00 – 13:00<br />
WS23:<br />
Infection of the<br />
Immunocompromised<br />
WS24:<br />
Zoonotic Viruses<br />
Plenary Session 4:<br />
Next Generation<br />
Viromics<br />
09:45 – 10:00 Survival and immunological improvement of ART-naïve HIV patients by HPgV<br />
coinfection<br />
Gibran Horemheb-Rubio, Mexico City, Mexico<br />
10:00 – 10:15 Immune reconstitution hepatitis A in a patient with AIDS demonstrates the<br />
importance of immunopathology<br />
Thomas Harrer, Erlangen, Germany<br />
10:15 – 10:30 Hepatitis E at a tertiary center in Northern Germany<br />
Dirk Westhölter, Hamburg, Germany<br />
Chairpersons Gülsah Gabriel, Hamburg, Germany<br />
Noël Tordo, Paris, France<br />
08:30 – 09:00 Keynote: Ebola and Rabies, bats and dogs: Differences and similarities<br />
between two zoonoses, applicability of the “One Health“ concept<br />
Noël Tordo, Paris, France<br />
09:00 – 09:15 The sialic acid binding preference determines the differential interaction between<br />
influenza A viruses and streptococci<br />
Jie Tong, Hannover, Germany<br />
09:15 – 09:30 The neuraminidase protein of novel H7N9 virus displays reduced enzymatic<br />
activity resulting from mutation of the 2nd sialic acid binding site<br />
Meiling Dai, Utrecht, The Netherlands<br />
09:30 – 09:45 Host-symbionts interaction driving evolution of alpha and beta coronaviruses<br />
(CoVs) in their bat hosts<br />
Stefania Leopardi, Legnaro, Italy<br />
09:45 – 10:00 Bat coronaviruses in France and Western Palearctic: After MERS-CoV and<br />
SARS-CoV, are there other candidates to emergence?<br />
Meriadeg Ar Gouilh, Paris, France<br />
10:00 – 10:15 Stem cell-derived hepatocellular systems for the study of genuine pangenotype<br />
hepatitis E virus replication<br />
Viet Loan Dao Thi, New York City NY, USA<br />
10:15 – 10:30 PTLV-1 among humans in two regions of tropical Africa<br />
Grit Schubert, Berlin, Germany<br />
10:30 – 11:00 Coffee Break Foyer D-G; Hall G, D and E – 2.Floor<br />
Chairpersons Adam Grundhoff, Hamburg, Germany<br />
Albert Osterhaus, Hannover, Germany<br />
11:00 – 11:30 Virus genome variation in infected individuals and populations<br />
Paul Kellam, Cambridge, UK<br />
11:30 – 12:00 The merging of fields through NGS applications in emerging infectious<br />
diseases<br />
Marion Koopmans, Rotterdam, The Netherlands<br />
12:00 – 12:30 Viral signatures of immune control of HIV and HCV<br />
Todd Allen, Cambridge MA, USA<br />
12:30 – 13:00 Virus discovery in human and animals: From genomes to diseases<br />
Eric Delwart, San Francisco CA, USA<br />
13:00 – 15:00 Lunch Break Foyer D-G; Hall G, D and E – 2.Floor<br />
Hall A – 1. Floor<br />
Hall B – 1. Floor<br />
Hall 1 – 2. Floor<br />
Satellite<br />
Symposium<br />
13:15 – 14:45<br />
Erasmus MC / Institut Pasteur Symposium:<br />
“Emerging Zoonoses“<br />
Hall A –<br />
1. Floor<br />
Satellite<br />
Symposium<br />
13:15 – 14:45<br />
ESV – Symposium:<br />
”Challenges in Clinical Virology”<br />
Hall F –<br />
2. Floor<br />
15:00 – 17:00<br />
WS25:<br />
Curative Strategies<br />
for Virus<br />
Eradication<br />
Chairpersons Ulrike C. Lange, Hamburg, Germany<br />
Thomas F. Baumert, Strasbourg, France<br />
15:00 – 15:30 Keynote: Cell circuits of viral entry, disease biology and antiviral therapy<br />
Thomas F. Baumert, Strasbourg, France<br />
15:30 – 16:00 Keynote: Genome editing as antiviral therapy<br />
Frank Buchholz, Dresden, Germany<br />
Hall 1 –<br />
2. Floor<br />
31
6 th<br />
European Congress of Virology<br />
Detailed <strong>Programme</strong><br />
Saturday, 22 nd October<br />
15:00 – 17:00<br />
15:00 – 17:00<br />
15:00 – 17:00<br />
WS25:<br />
Curative Strategies<br />
for Virus<br />
Eradication<br />
WS26:<br />
Virus Discovery,<br />
Typing and<br />
Metagenomics<br />
WS27:<br />
Vector Borne<br />
Infections<br />
WS28:<br />
Best of Posters<br />
16:00 – 16:15 Novel targets for potent antiviral drugs: The development of Pritelivir and<br />
Letermovir against viruses from the herpes group<br />
Helga Rübsamen-Schaeff, Frankfurt, Germany<br />
16:15 – 16:30 Natural humic substances interfere with multiple stages of the replication<br />
cycle of human immunodeficiency virus<br />
Yury Zhernov, Moscow, Russian Federation<br />
16:30 – 16:45 Antiviral activity of apigenin against African swine fever virus<br />
Hovakim Zakaryan, Yerevan, Armenia<br />
Chairpersons Nicole Fischer, Hamburg, Germany<br />
Eric Delwart, San Francisco CA, USA<br />
15:00 – 15:30 Keynote: Animal viruses leaving the animal-human interface<br />
Albert Osterhaus, Hannover, Germany<br />
15:30 – 15:45 Polymycoviridae: An emerging family of mycoviruses<br />
Ioly Kotta-Loizou, London, UK<br />
15:45 – 16:00 Discovery and characterization of a new avian hepatitis B virus in a palaeognath<br />
bird<br />
Wendy K. Jo, Hannover, Germany<br />
16:00 – 16:15 Co-circulation of potentially novel paramyxoviruses in bats in Central Brazil<br />
William Marciel Souza, Ribeirão Preto, Brazil<br />
16:15 – 16:30 Investigation of hantavirus prevalence in wild rodent population in the<br />
United Kingdom<br />
Joe Chappell, Nottingham, UK<br />
16:30 – 16:45 Sero- and genoepidemiology of two human protoparvoviruses, bufavirus<br />
and tusavirus<br />
Elina Väisänen, Helsinki, Finland<br />
16:45 – 17:00 HERV-W group evolutionary history: Characterization of the group in nonhuman<br />
primates and identification of highly related sequences in new world<br />
monkeys<br />
Nicole Grandi, Cagliari, Italy<br />
Chairpersons Daniel Cadar, Hamburg, Germany<br />
Stéphane Blanc, Montpellier, France<br />
15:00 – 15:30 Keynote: Vector transmission: Commonalities and specificities in plant and<br />
animal viruses<br />
Stéphane Blanc, Montpellier, France<br />
15:30 – 16:00 Keynote: Zika virus pathogenesis<br />
Helen Lazear, Chapel Hill NC, USA<br />
16:00 – 16:15 Interaction between flaviviruses and alphaviruses during coinfection at the<br />
cell level<br />
Dimitri Lavillette, Shanghai, China<br />
16:15 – 16:30 Mosquito saliva increases endothelial permeability in the skin, immune cell<br />
migration and dengue pathogenesis during antibody-dependent enhancement<br />
Michael A. Schmid, Berkeley CA, USA<br />
16:30 – 16:45 Alpha-repeat molecules as novel antivirals against flaviviruses by targeting<br />
the envelope glycoprotein and the NS1 protein<br />
Wilhelm Furnon, Lyon, France<br />
16:45 – 17:00 Antiviral piRNA pathway in the arbovirus vector Aedes aegypti<br />
Margus Varjak, Glasgow, UK<br />
Chairpersons Julian Schulze zur Wiesch, Hamburg, Germany<br />
Karin Mölling, Berlin, Germany<br />
15:00 – 17:00 Short presentations selected from Poster Sessions<br />
17:15 – 18:00<br />
Life Science Nord – Poster Prize<br />
Farewell – Next Meeting Presentation<br />
Hall 1 – 2. Floor<br />
Hall F – 2. Floor<br />
Hall A – 1. Floor<br />
Hall B –<br />
1. Floor<br />
Hall 1 –<br />
2.Floor<br />
32
Poster Exhibition and Poster Sessions<br />
Scientific posters will be presented in the following topic groups:<br />
Immunity<br />
WS 1, 2, 5, 9, 13, 20, 23<br />
Hall E<br />
Zoonoses, Emerging Infections<br />
WS 14, 22, 24, 26, 27<br />
WS 18<br />
Hall D<br />
Hall E<br />
Basic Virology<br />
WS 3, 4, 6, 8, 10, 15, 16, 19, 21<br />
Foyer Hall D-G<br />
Clinical Virology<br />
WS 7, 11, 12, 17, 25<br />
Hall E<br />
There will be a Poster Session for each Poster Workshop. Please check the following<br />
pages for the specific date and time of the session.<br />
Soft drinks and Pretzels will be offered during the Poster Sessions.<br />
33
6 th<br />
European Congress of Virology<br />
Poster Sessions<br />
WS-1 Innate Antiviral Immunity<br />
and Viral Immune<br />
Evasion<br />
19 th Oct. 2016<br />
18:00 – 20:00<br />
Hall E<br />
P1-2 Cytomegalovirus’ evasion from the peroxisomedependent<br />
antiviral immune response<br />
Daniela Ribeiro, University of Aveiro, Aveiro, Portugal<br />
P1-3 Host factors interfering with early events of<br />
cytomega lovirus infection and viral gene expression<br />
Ulfert Rand, Helmholtz Centre for Infection Research,<br />
Braunschweig, Germany<br />
P1-4 Killer-cell immunoglobulin-like receptors and<br />
cytomega lovirus reactivation during late pregnancy<br />
Diana Lorena Alvarado Hernández, Universidad Autónoma<br />
de San Luis Potosí, San Luis Potosi, Mexico<br />
P1-5 Human Cytomegalovirus pp65 inhibits Interferon<br />
type I production through its interaction with the<br />
cGAS/STING axis<br />
Sara Pautasso, University of Turin, Turin, Italy<br />
P1-6 avb3-integrin cooperates with the IFN receptor<br />
signa ling and controls PD-L1 expression<br />
Tatiana Gianni, University of Bologna, Bologna, Italy<br />
P1-7 KIR2DL2 activation by human Herpesviruses determines<br />
viral escape to innate immunity<br />
Roberta Rizzo, University of Ferrara, Ferrara, Italy<br />
P1-8 The innate response against oncolytic HSV retargeted<br />
to cancer specific receptors<br />
Andrea Vannini, University of Bologna, Bologna, Italy<br />
P1-9 Varicella zoster virus expresses a broad-range<br />
chemokine binding protein that enhances<br />
chemokine activity<br />
Víctor González Motos, Medizinische Hochschule<br />
Hannover (MHH), Hannover, Germany<br />
P1-10 Influence of genotype A Hepatitis B virus envelope<br />
variability on HBs antigen (HBsAg) persistence in<br />
patients mono-infected or co-infected with human<br />
immun odeficiency virus<br />
Hélène Jeulin, Université de Lorraine, Vandoeuvre-les-<br />
Nancy, France<br />
P1-11 Cleavage of MAVS and interference with innate<br />
immune signaling is conserved among hepaciviral<br />
NS3/4A proteases<br />
Angga Kusuma, TWINCORE – Centre for Experimental<br />
and Clinical Infection Research, Hannover,<br />
Germany<br />
P1-12 HLA-Bw4 80(T) and high HLA-Bw4 copy numbers<br />
in combination with KIR3DL1 are associated with<br />
superior immune control of HCV infection in people<br />
who inject drugs<br />
Jörg Timm, University Hospital Düsseldorf, Heinrich-<br />
Heine-University, Düsseldorf, Germany<br />
P1-13 Peroxisomal MAVS is targeted by Hepatitis C virus<br />
NS3-4A to disrupt antiviral signalling response<br />
Ana Rita, Ferreira, University of Aveiro, Aveiro,<br />
Portugal<br />
P1-14 Establishing robust induced pluripotent stem<br />
cell-derived model systems to study hepatitis C<br />
virus-host interactions<br />
Anja Schöbel, Heinrich Pette Institute, Leibniz Institute<br />
for Experimental Virology, Hamburg, Germany<br />
P1-15 Hepatitis E virus infection induces an innate immune<br />
response in human chimeric mice<br />
Lena Allweiss, Universitätsklinikum Eppendorf, Hamburg,<br />
Germany<br />
P1-16 Unphosphorylated ISGF3 drives constitutive<br />
transcription of interferon-stimulated genes and<br />
provides host antiviral defense<br />
Wenshi Wang, Erasmus MC, Rotterdam, Netherlands<br />
P1-17 Reduced CD8+CD161+ MAIT cells in HCV and<br />
HIV/HCV co-infection<br />
Johanna Maria Eberhard, Universitätsklinikum Eppendorf,<br />
Hamburg, Germany<br />
P1-18 Increased frequency of CD39+ CD56bright Natural<br />
Killer cells in HIV-1 infection correlates with immune<br />
activation and disease progression<br />
Patrick Dirks, Universitätsklinikum Eppendorf, Hamburg,<br />
Germany<br />
P1-19 The cellular transcription factor ZNF395 is involved<br />
in the control of HIV-1 replication in vivo and in<br />
vitro<br />
Gertrud Steger, Institute of Virology, Cologne,<br />
Germany<br />
P1-21 Nuclear RIG-I exhibits antiviral activity against<br />
influenza virus<br />
Michaela Weber-Gerlach, Justus-Liebig University,<br />
Gießen, Germany<br />
P1-22 Effect of Middle East Respiratory Syndrome<br />
Corona virus (MERS-CoV) Spike glycoprotein on<br />
macrophage innate immune response<br />
George Sourvinos, University of Crete, Heraklion,<br />
Greece<br />
P1-23 Impact of host interferon-stimulated-gene-product<br />
15 biodiversity on the deISGylase function of<br />
coronavirus Papain-like proteases<br />
Courtney Daczkowski, University of Georgia, Athens,<br />
United States<br />
P1-24 Contribution of host and viral small non-coding<br />
RNAs to SARS-CoV lung pathology<br />
Lucia Morales, National Center of Biotechnology,<br />
Madrid, Spain<br />
P1-25 Early endonuclease-mediated evasion of RNA sensing<br />
ensures efficient coronavirus replication<br />
Eveline Patricia Kindler, Institute of Virology and<br />
Immuno logy, Bern, Switzerland<br />
P1-26 The unfolded protein response is a prerequisite for<br />
Flavivirus-mediated interferon induction<br />
Alessandro Marcello, ICGEB, Trieste, Italy<br />
P1-27 In vitro approach to study interactions of pathogenic<br />
and non-pathogenic hantaviruses with their<br />
natural and human hosts<br />
Myriam Ermonval, Institut Pasteur, Paris, France<br />
P1-28 Genetic modification of primary human airway<br />
epithelium – a platform for the study of respiratory<br />
viruses Hulda R. Jonsdottir, Institute of Virology and<br />
Immunology, Bern, Switzerland<br />
P1-29 A comparative study of respiratory syncytial virus<br />
(RSV) infection of macrophage cell lines reveals<br />
remarkable differences in susceptibility<br />
Peter Delputte, University of Antwerp, Antwerpen,<br />
Belgium<br />
34
P1-30 Biodiversity impact of host interferon-stimulatedgene-product<br />
15 on the function of nairoviral<br />
deISGylases John Dzimianski, University of Georgia,<br />
Athens, United States<br />
P1-31 Commensal bacteria-mediated IL-22 expression<br />
determines susceptibility of adult mice to Rotavirus<br />
infection Daniel Schnepf, Universitätsklinikum<br />
Freiburg, Freiburg im Breisgau, Germany<br />
P1-32 IFN induction by rabies and other lyssaviruses:<br />
identi fication of critical residues in the viral<br />
phosphoprotein P Marco Wachowius, LMU Munich,<br />
Munich, Germany<br />
P1-34 Differing substrate specificity among PRRSV<br />
vOTUs, Scott Pegan, University of Georgia, Athens,<br />
United States<br />
WS-2 Restriction Factors of<br />
Viral Infection<br />
19 th Oct. 2016<br />
18:00 – 20:00<br />
Hall E<br />
P2-1 Murine cytomegalovirus M117 is an E2F regulator<br />
and functions as a host range determinant<br />
Eleonore Ostermann, Heinrich Pette Institute,<br />
Leibniz Institute for Experimental Virology, Hamburg,<br />
Germany<br />
P2-2 Regulatory interaction between the cellular restriction<br />
factor IFI16 and viral pp65 (pUL83) modulates<br />
viral gene expression and IFI16 protein stability<br />
Matteo Biolatti, University of Turin, Turin, Italy<br />
P2-3 SamHD1 restricts human cytomegalovirus (HCMV)<br />
Ramona Businger, Institute of Medical Virology, Tübingen,<br />
Germany<br />
P2-4 Merkel cell polyomavirus (MCPyV) replication is<br />
negatively regulated by the host restriction factor<br />
Kap1/TRIM28<br />
Svenja Siebels, University Medical Center Hamburg-<br />
Eppendorf, Hamburg, Germany<br />
P2-5 Identification of the nuclease involved in interferon-induced<br />
purging of HBV cccDNA<br />
Daniela Stadler, Technische Universität München /<br />
Helmholtz Zentrum München, Munich, Germany<br />
P2-7 Analysis of APOBEC3G-mediated inhibition of<br />
Measles Virus replication<br />
Vishakha Tiwarekar, University of Würzburg, Würzburg,<br />
Germany<br />
P2-8 Tetherin counteraction by the Ebola virus glycoprotein<br />
Julia Nehls, Helmholtz Zentrum München<br />
– German Research Center for Environmental Health,<br />
Oberschleißheim, Germany<br />
P2-9 SARS-CoV replication is down-regulated by p53 via<br />
interaction of the SARS-Unique Domain and PLpro<br />
with E3 ubiquitin ligase RCHY1<br />
Albrecht von Brunn, Max-von-Pettenkofer Institute/<br />
LMU München, München, Germany<br />
P2-11 Interplay between the cellular restriction factor<br />
PML and dengue virus<br />
Federico Giovannoni, School of Sciences, University<br />
of Buenos Aires, Buenos Aires, Argentina<br />
P2-12 Viperin biogenesis and antiviral effect against<br />
TBEV<br />
Arun Upadjyay, Umeå University, Umea, Sweden<br />
P2-13 ARTD8 (PARP14) is involved in restriction of viral<br />
replication<br />
Matthias Liniger, Institute of Virology and Immunology<br />
(IVI), Federal Food Safety and Veterinary Office and<br />
Vetsuisse Faculty, Mittelhäusern, Switzerland<br />
P2-14 The antiviral potential of hypertonic response in<br />
Coxsackievirus infection: a novel direction for drug<br />
development<br />
Ye Qiu, University of British Columbia, Vancouver,<br />
Canada<br />
P2-15 Control of Pepper mild mottle virus and Cucumber<br />
green mottle mosaic virus tobamoviruses collected<br />
in South Korea by Pseudomonas oleovorans<br />
Hyoun-Sub Lim, Chungnam National University,<br />
Daejeon, Korea, Republic of<br />
WS-3 Virus Attachment and 19 th Oct. 2016<br />
Foyer D-G<br />
Entry<br />
18:00 – 20:00<br />
P3-1 Infection and replication efficiency of different<br />
human cytomegalovirus glycoprotein O genotype<br />
mutants<br />
Julia Kalser, Medical University of Vienna, Vienna,<br />
Austria<br />
P3-2 Confocal microscopy analysis reveals novel aspects<br />
of cell-to-cell spread of alphaherpesviruses<br />
Krystyna Bienkowska-Szewczyk, University of Gdansk,<br />
Gdansk, Poland<br />
P3-3 Entry of herpes simplex virus 1 into human oral<br />
mucosa Dagmar Knebel-Mörsdorf, University of<br />
Cologne, Cologne, Germany<br />
P3-4 Chimeric gB re-addresses HSV tropism to HER2<br />
and bypasses the receptor-mediated activation of<br />
the upstream glycoproteins gD and gH<br />
Biljana Petrovic, University of Bologna, Bologna, Italy<br />
P3-5 The Ephrin A2 receptor tyrosin kinase (EphA2)<br />
is downregulated by the KSHV immediate-early<br />
transactivator RTA<br />
Frank Neipel, Universitaetsklinikum Erlangen, Erlangen,<br />
Germany<br />
P3-6 Analysis of the role of Nup153 in the stability of<br />
HBV Capsid under in vitro conditions mimicking<br />
the nuclear basket<br />
Lara Gallucci, UMR 5234 Microbiologie Fondamentale<br />
et Pathogénicité CNRS - University of Bordeaux,<br />
Bordeaux, France<br />
P3-7 CD81 receptor regions outside the large extracellular<br />
loop determine hepatitis C virus susceptibility<br />
Gisa Gerold, Twincore, Center for Experimental and<br />
Clinical Infection Research, Hannover, Germany<br />
P3-8 Retroviral envelope glycoprotein: key or picklock?<br />
David P ikryl, Institute of Molecular Genetics of the<br />
ASCR, v. v. i., Prague, Czech Republic<br />
P3-9 G-Quadruplex-based approaches to inhibit the<br />
HIV-1 entry process<br />
Rosalba Perrone, University of Padua, Padua, Italy<br />
P3-10 Morphological and functional changes in the welldifferentiated<br />
airway epithelium after infection by<br />
influenza virus<br />
Nai-Huei Wu, University of Veterinary Medicine Hannover,<br />
Hannover, Germany<br />
P3-12 Receptor binding by H10N7 influenza viruses<br />
isolated from seals<br />
Jie Zhang, Francis Crick Institute Mill Hill Laboratory,<br />
London, United Kingdom<br />
35
6 th<br />
European Congress of Virology<br />
Poster Sessions<br />
P3-13 Studying Influenza A virus-receptor interactions<br />
using biolayer interferometry<br />
Hongbo Guo, Utrecht University, Utrecht, Netherlands<br />
P3-14 Distinct structural features of human enteric<br />
adenoviruses 40 and 41 as determinants affecting<br />
entry into host cells<br />
Martha Brown, University of Toronto, Toronto, Canada<br />
P3-15 AMV248 open reading frame of Amsacta moorei<br />
entomopoxvirus (AMEV) encodes a glycosyl transferase<br />
playing a role in virus attachment<br />
Zihni Demirbag, Karadeniz Technical University,<br />
Trabzon, Turkey<br />
P3-17 Respiratory syncytial virus (RSV) entry is inhibited<br />
by serine protease inhibitor AEBSF when present<br />
during early stage infection<br />
Winke, Van der Gucht, University of Antwerp, Wilrijk,<br />
Belgium<br />
P3-18 Elucidating autophagy-mediated-uncoating process<br />
of Dengue virus by single-virus FRET imaging<br />
Li-Wei Chu, National Yang-Ming University, Taipei,<br />
Taiwan, Republic of China<br />
P3-19 Integrin avb3 is necessary for efficient flavivirus<br />
replication in mouse cell lines<br />
Vinicius Pinho dos Reis, Friedrich-Loeffler-Institut,<br />
Greifswald - Insel Riems, Germany<br />
P3-20 Receptor engagement of the porcine epidemic<br />
diarrhea virus<br />
Berend-Jan Bosch, Utrecht University, Utrecht,<br />
Netherlands<br />
P3-21 Role of early steps of infection in the resistance<br />
of pancreatic cancer cells to oncolytic vesicular<br />
stomatitis virus<br />
Sebastien Felt, University of North Carolina at Charlotte,<br />
Charlotte, United States<br />
P3-22 Native mass spectrometry analysis of interactions<br />
between noroviruses and glycan mimetics<br />
Hao Yan, Heinrich-Pette-Institut, Hamburg, Germany<br />
P3-23 Native mass spectrometry demonstrates the role<br />
of glycans in pathogen infection<br />
Julia Lockhauserbäumer, Heinrich Pette Institute,<br />
Hamburg, Germany<br />
P3-24 Structural characterization of protein-lipid complexes<br />
involved in viral entry<br />
Johannes Heidemann, Heinrich Pette Institute,<br />
Leibniz Institute for Experimental Virology, Hamburg,<br />
Germany<br />
WS-4 Virus Replication 19 th Oct. 2016<br />
Foyer D-G<br />
Strategies<br />
18:00 – 20:00<br />
P4-2 UL11 is essential for equine herpesvirus 1 replication<br />
in cell culture<br />
Yassien Badr, Gifu University, Gifu city, Japan<br />
P4-3 Perilipin-2 regulates lipid droplet morphology and<br />
Hepatitis C Virus replication<br />
Susan Lassen, Heinrich Pette Institute, Hamburg,<br />
Germany<br />
P4-4 Hepatitis C Virus infection perturbs the lipid<br />
profile of the host cell<br />
Sarah Hofmann, Heinrich Pette Institute, Hamburg,<br />
Germany<br />
P4-5 Hepatitis E virus replication and interferon response<br />
in human placental-derived cells<br />
Leonard Knegendorf, Institute for Experimental Virology,<br />
TWINCORE, Centre for Experimental and Clinical<br />
Infection Research; a joint venture between the Medical<br />
School Hannover (MHH) and the Helmholtz Centre<br />
for Infection Research (HZI), Hannover, Germany<br />
P4-6 Replication properties among H9N2 avian influenza<br />
viruses of Eurasian origin, Rokshana<br />
Parvin Bangladesh, Agricultural University, Mymensingh,<br />
Bangladesh<br />
P4-7 Role of G6PD activity in regulating influenza virus<br />
replication<br />
Donatella Amatore, University of Rome ‘Sapienza’,<br />
Rome, Italy<br />
P4-8 Identification of virus-host interactions at the coronavirus<br />
replicative structures using a proximitylabelling<br />
approach<br />
Philip V’kovski, Institute of Virology and Immunology<br />
IVI, Bern, Switzerland<br />
P4-9 Mutagenization of the MCPyV non coding control<br />
region (NCCR) to improve late gene expression<br />
Emma Kraus, Heinrich Pette Institute, Leibniz Institute<br />
for Experimental Virology, Hamburg, Germany<br />
P4-10 The ubiquitin proteasome system is necessary for<br />
efficient human Astrovirus replication,<br />
Luis Alberto, Casorla-Pérez, National University of<br />
Mexico, Cuernavaca, Mexico<br />
P4-11 Characterizing the role of the NS1-NS4B interaction<br />
for the Dengue virus life cycle<br />
Anna Płaszczyca, Heidelberg University, Heidelberg,<br />
Germany<br />
P4-13 Nuclear localisation of West Nile virus non structural<br />
protein 5 is crucial for viral replication<br />
Adam Lopez-Denman, University of Melbourne /<br />
Peter Doherty Institute for Infection and Immunity,<br />
Melbourne, Australia<br />
P4-14 Genome-wide CRISPR/Cas9 screens to identify<br />
essential host factors for viral infections<br />
Friderike Weege, Max Planck Institute for Infection<br />
Biology, Berlin, Germany<br />
WS-5 Adaptive Antiviral<br />
Immunity and Viral<br />
Immune Evasion<br />
20 th Oct. 2016<br />
17:30 – 19:30<br />
Hall E<br />
P5-1 IFN-g 874 T/A polymorphisms in HBV patients in<br />
Khartoum State-Sudan<br />
Abdelaziz Atta, Central Laboratory, Ministry of Higher<br />
Education and Scientific Research, Khartoum, Sudan<br />
P5-2 HEV specific T-cell response in immunosuppressed<br />
and immunocompetent patients with acute or<br />
chronic hepatitis E<br />
Johanna Blöcker, University Medical Center Hamburg-<br />
Eppendorf, Hamburg, Germany<br />
P5-3 Analysis of HLA-C7-restricted CTL targeting a<br />
conserved epitope in HIV-1 Nef.<br />
Thomas Harrer, Universitätsklinikum Erlangen, Erlangen,<br />
Germany<br />
P5-4 Antibody-induced internalization of the human<br />
respiratory syncytial virus fusion protein<br />
Annelies Leemans, University of Antwerp, Antwerp,<br />
Belgium<br />
36
P5-5 Specificities and immunodominance of human CD4<br />
T cell responses to the live-attenuated yellow fever<br />
vaccine<br />
Judith H. Aberle, Medical University of Vienna,<br />
Vienna, Austria<br />
WS-6 Virus Maturation and 20 th Oct. 2016<br />
Foyer D-G<br />
Egress<br />
17:30 – 19:30<br />
P6-1 The presumed polyomavirus viroporin VP4 of SV40<br />
or BKPyV is not required for viral progeny release<br />
Christine Hanssen Rinaldo, University Hospital of<br />
North Norway,Tromsø, Norway<br />
P6-2 Herpes simplex membrane proteins gE/gI and<br />
US9 promote entry of virus particles into neuronal<br />
axons, initiating anterograde transport toward<br />
axon tips, by kinesin-1 motors<br />
David Johnson, Oregon Health & Sciences University,<br />
Portland, United States<br />
P6-3 RhoB GTPase is implicated in Herpes simplex virus<br />
type-1 (HSV-1) infection<br />
George Sourvinos, University of Crete, Heraklion,<br />
Greece<br />
P6-4 Cellular localization of UL11 protein in equine<br />
herpesvirus 1 infected cells<br />
Yassien Badr, Gifu University, Gifu city, Japan<br />
P6-5 Identification of the ATP-binding site in the helicase<br />
subunit pUL105 of human cytomegalovirus<br />
GAETAN Ligat, Univ. Limoges, UMR 1092, Limoges,<br />
France<br />
P6-6 Hepatitis C virus is released via a non-canonical<br />
secretory route<br />
Linda Wiltzer-Bach, University Clinic Tübingen,<br />
Tübingen, Germany<br />
P6-7 Extracellular maturation of secreted hepatitis C<br />
virus particles by incorporation of Apoliporotein<br />
E enhances infectivity and partially protects from<br />
neutralizing antibodies<br />
Dorothea Bankwitz, TWINCORE, Centre for Experimental<br />
and Clinical Infection Research; a joint venture<br />
between the Medical School Hannover (MHH) and<br />
the Helmholtz Centre for Infection Research (HZI),<br />
Hannover, Germany<br />
P6-8 Quantitative lipid droplet proteome analysis identifies<br />
Annexin A3 as a cofactor for HCV particle<br />
production Kathrin Rösch, Heinrich Pette Institute,<br />
Leibniz Institute for Experimental Virology, Hamburg,<br />
Germany<br />
P6-9 Novel stem cell-derived polarized hepatocellular<br />
systems for the studies of hepatitis E virus<br />
secretion<br />
Viet Loan, Dao Thi, Rockefeller University, New York<br />
City, United States<br />
P6-10 Involvement of AIP1/Alix in the Feline Immunodeficiency<br />
Virus egress from infected cells<br />
Arianna Calistri, University of Padova, Padova, Italy<br />
P6-11 Elucidating the composition of a “transport of p8<br />
complex” (TOPC) to understand transfer of HTLV-1<br />
p8 to target cells<br />
Andrea K. Thoma-Kress, Institute of Clinical and<br />
Molecular Virology, Friedrich-Alexander-Universität<br />
Erlangen-Nürnberg (FAU), Erlangen, Germany<br />
P6-12 The hemagglutinin of a H5N1 highly pathogenic<br />
avian influenza virus exhibits a high pH threshold<br />
of fusion but does not rely on the ion channel<br />
protein M2 for maturation<br />
Gert Zimmer, Institute of Virology and Immunology<br />
(IVI), Federal Food Safety and Veterinary Office and<br />
Vetsuisse Faculty, Mittelhäusern/Bern, Switzerland<br />
P6-13 Membrane budding regulated by a critical residue<br />
located at the putative dimeric interface of the<br />
canine distemper virus matrix protein<br />
Fanny Bringolf, University of Bern, Vetsuisse Faculty,<br />
Bern, Switzerland<br />
P6-14 Dengue viruses are egressed in extracellular<br />
vesicles Chih-Ling Liu, National Yang-Ming University,<br />
Taipei, Taiwan, Republic of China<br />
P6-15 Monitoring physiological changes of a haloarchaeon<br />
during the exit of viruses<br />
Julija Svirskaite, University of Helsinki, Helsinki,<br />
Finland<br />
WS-7 Advanced Virus 20 th Oct. 2016<br />
Hall E<br />
Diagnosis<br />
17:30 – 19:30<br />
P7-1 Introduction of self-sampling for Human Papillomavirus-DNA<br />
detection in Cochabamba, Bolivia: A<br />
preliminary study of compliance and feasibility<br />
Pedro Surriabre, Universidad Mayor de San Simon,<br />
Cochabamba, Bolivia<br />
P7-2 Detection and quantification of infectious adenoviruses<br />
in the early stages of infection – ICC-qPCR<br />
versus immunolabeling<br />
Mihayl Varbanov, Université de Lorraine, Nancy,<br />
France<br />
P7-3 Validation of the RealStar® Orthopoxvirus PCR Kit<br />
1.0 for detection of Orthopoxvirus and differentiation<br />
of variola virus<br />
Stephan Ölschläger, altona Diagnostics GmbH,<br />
Hamburg, Germany<br />
P7-4 Microsphere-based IgG avidity assays using as<br />
model human Parvovirus B19 and CMV<br />
Yilin Wang, University of Helsinki, Helsinki, Finland<br />
P7-5 Diagnostic value of pathogen specific antibody<br />
coefficients in uveitis patients<br />
Mario Hönemann, Institute of Virology, Leipzig University,<br />
Leipzig, Germany<br />
P7-6 Evaluation of the performance of four Herpes<br />
Simplex Virus (HSV) immunofluorescence assay<br />
(IFA) slides for the detection of HSV IgM<br />
Judith Chui Ching Wong, Singapore General Hospital,<br />
Singapore, Singapore<br />
P7-7 Discrepancy of anti-HEV test results determined by<br />
different seroassays<br />
Werner Dammermann, University Medical Center<br />
Brandenburg, Brandenburg an der Havel, Germany<br />
P7-8 Expression of recombinant Mouse Hepatitis Virus<br />
proteins in Escherichia coli for the improvement of<br />
diagnostic assays<br />
Julia Nickolaus, Leipzig University, Faculty of Veterinary<br />
Medicine, Leipzig, Germany<br />
P7-10 Evaluation of RealStar RT-PCR kits for filovirus<br />
detection in the laboratory and field<br />
Toni Rieger, Bernhard Nocht Institute for Tropical<br />
Medicine, Hamburg, Germany<br />
37
6 th<br />
European Congress of Virology<br />
38<br />
Poster Sessions<br />
P7-11 Evaluation of a real-time RT-PCR kit for detection<br />
of Lassa virus<br />
Stephan Ölschläger, altona Diagnostics GmbH,<br />
Hamburg, Germany<br />
P7-12 Development and validation of a sensitive and<br />
specific real-time RT-PCR system for the qualitative<br />
detection of Enterovirus and Rhinovirus RNA<br />
Mareen Zaruba, altona Diagnostics GmbH, Hamburg,<br />
Germany<br />
P7-13 Validation of the RealStar® Dengue Type RT-PCR<br />
Kit 1.0 for differentiation of dengue virus types 1-4<br />
Stephan Ölschläger, altona Diagnostics GmbH,<br />
Hamburg, Germany<br />
P7-14 Universal primers to detect emerging Reptarnaviruses<br />
Hasan Alrashedi, University of Reading,<br />
Reading, United Kingdom<br />
P7-15 The production of monoclonal antibodies against<br />
pestiviral immunogenic proteins for diagnostic<br />
purpose<br />
Tuba Cigdem Oguzoglu, Ankara University Veterinary<br />
Faculty, Ankara, Turkey<br />
P7-17 Screening of nasal swabs from patients from<br />
Casablanca (Morocco) with respiratory symptoms<br />
of unknown etiology<br />
Janine Michel, Robert Koch Institute, Berlin, Germany<br />
P7-18 Plaque assay optimization of the Newcastle<br />
disease virus in chicken embryo fibroblast cell line<br />
(DF1)<br />
Ray Izquierdo-Lara, Farvet S.A.C, Chincha Alta, Peru<br />
P7-20 Cell-based biosensors for detection and quantification<br />
of label-free virus and viral vectors for<br />
research and diagnostics<br />
Miguel Ricardo Guerreiro, iBET – Instituto de Biologia<br />
Experimental e Tecnológica, Oeiras, Portugal<br />
20<br />
WS-8 Viral Pathogenesis<br />
th Oct. 2016<br />
Foyer D-G<br />
17:30 – 19:30<br />
P8-1 Human papillomavirus infection – a possible cause<br />
of spontaneous abortion and spontaneous preterm<br />
delivery<br />
Lea Maria Margareta Ambühl, North Denmark Regional<br />
Hospital/Aalborg University, Hjørring, Denmark<br />
P8-2 Merkel cell polyomavirus T antigens upregulate<br />
IL17F activity in Merkel cell carcinoma<br />
Kashif Rasheed, University of Tromsø, Tromsø, Norway<br />
P8-3 Analysis of the molecular mechanisms underlyning<br />
the different susceptibility of breast adenocarcinoma<br />
derived cell lines to g-34.5 deleted herpes<br />
simplex virus type 1 replication<br />
Adriana Vitiello, University of Padova, Padova, Italy<br />
P8-4 Role of pattern recognition receptors in the pathogenesis<br />
of Herpes simplex virus -1 induced uveitis<br />
in a rabbit animal model<br />
Archit Kumar, PGIMER, Chandigarh, India<br />
P8-5 Infectivity and cytopathogenicity after infection<br />
with herpes simplex virus type 1 or 2 during differentiation<br />
to human cortical neurons from induced<br />
pluripotent stem cells<br />
Tomas Bergström, University of Gothenburg, Gothenburg,<br />
Sweden<br />
P8-6 Interaction of the HSV-2 regulator protein ICP0<br />
with the cellular E3 ubiquitin ligase SIAH-1<br />
Julia Czechowicz, Heinrich Pette Institute, Leibniz<br />
Institute for Experimental Virology, Hamburg, Germany<br />
P8-7 Is HHV-6A associated to female infertility?<br />
Dario Di Luca, University of Ferrara, Ferrara, Italy<br />
P8-8 Effect of equine herpesvirus type 1 (EHV-1) infection<br />
of nasal mucosa epithelial cells on different<br />
elements of the extracellular matrix<br />
Hossein Bannazadeh Baghi, Infectious and Tropical<br />
Diseases Research Center,Tabriz University of Medical<br />
Sciences, Tabriz, Iran, Islamic Republic of<br />
P8-9 Hepatic microRNA expression levels are associated<br />
with clinical parameters in Russian patients with<br />
chronic hepatitis C<br />
Tatyana Viktorovna Vishnevskaya, N.F Gamaleya<br />
Federal Research Center for Epidemiology and Microbiology,<br />
Moscow, Russian Federation<br />
P8-10 Membranoproliferative glomerulonephritis associated<br />
with an HIV infection<br />
Hicham Rafik, Military Hospital, Rabat, Morocco<br />
P8-11 Contribution of gag, pol and env regions to overall<br />
viral replicative fitness of HIV-1 from patients<br />
without antiretroviral therapy<br />
Lenka Sácká, Institute of Organic Chemistry and<br />
Biochemistry ASCR, Prague, Czech Republic<br />
P8-12 The omega-3 docosahexaenoic acid boosts HIV-1<br />
infectivity in ex vivo treated CD4+ T cells<br />
Olivia Tort, IDIBAPS / Hospital Clínic, Barcelona, Spain<br />
P8-13 Reovirus infection alters host cell alternative splicing<br />
landscape<br />
Simon Boudreault, Université de Sherbrooke, Sherbrooke,<br />
Canada<br />
P8-14 HMGB1 is a potential biomarker for severe viral<br />
hemorrhagic fevers<br />
Misa Korva, University of Ljubljana, Faculty of Medicine,<br />
Ljubljana, Slovenia<br />
P8-15 Chimeric mice with competent hematopoietic<br />
Immunity reproduce key features of severe Lassa<br />
fever<br />
Lisa Oestereich, Bernhard Nocht Institute for Tropical<br />
Medicine, Hamburg, Germany<br />
P8-16 Mechanisms underlying the neuropathogenesis of<br />
Rabies virus<br />
Chloe Scordel, Ludwig-Maximilians-University Munich,<br />
Munich, Germany<br />
P8-17 Interactions of Pseudorabies virus with porcine<br />
maxillary nerve<br />
Konstantinos Papageorgiou, Aristotle University of<br />
Thessaloniki, Thessaloniki, Greece<br />
P8-18 Schmallenberg virus incursion into Great Britain:<br />
identification of mutations and a large deletion in<br />
the M segment of British field samples that result<br />
in attenuation of SBV<br />
Falko Steinbach, APHA, Addlestone, United Kingdom<br />
P8-20 A mutation in the membrane protein strongly affects<br />
pathogenesis of West Nile Flavivirus<br />
Nathalie Pardigon, Institut Pasteur, Paris, France<br />
P8-21 Type I Interferon response in olfactory bulb, the<br />
site of tick-borne flavivirus accumulation, is primarily<br />
regulated by IPS-1<br />
Chaitanya Kurhade, Molecular Infection Medicine,<br />
Sweden (MIMS), Umea University, Umea, Sweden<br />
P8-22 Classical swine fever virus and African swine fever<br />
virus interaction in experimentally infected wild<br />
boars<br />
Sara Muñoz-González, IRTA, Barcelona, Spain
P8-23 Two Isolates of Turnip mosaic virus show symptom<br />
differences in N. benthamiana, Raphanus sativus<br />
and Brassica rapa determined by the P3 protein<br />
Hyoun-Sub Lim, Chungnam National University,<br />
Daejeon, Korea, Republic of<br />
P8-24 Identification and characterization of Sugarcane<br />
mosaic virus causing Maize lethal necrotic disease<br />
in Kenya Henry Ondabu, University of Nairobi,<br />
Nairobi, Kenya<br />
P8-25 The Plum pox virus 6K1 protein is required for<br />
viral replication and targets the viral replication<br />
complex at the early infection stage<br />
Aiming Wang, Agriculture and Agri-Food Canada,<br />
London, Canada<br />
P8-26 Characteriztion of maize chlorotic mottle virus<br />
causing maize lethal necrosis disease in Kenya<br />
Nickson Sananka, University of Nairobi, Nairobi,<br />
Kenya<br />
WS-9 Humoral Immune<br />
Response to Viral<br />
Infection<br />
20 th Oct. 2016<br />
17:30 – 19:30<br />
Hall E<br />
P9-1 Production and characterization of monoclonal<br />
antibodies against yeast-expressed hepatitis E<br />
virus capsid proteins<br />
Martynas Simanavicius, Institute of Biotechnology of<br />
Vilnius University, Vilnius, Lithuania<br />
P9-2 Isolation and characterization of human memory<br />
B-cell antibodies against Chikungunya virus<br />
Oxana Vratskikh, Institut Pasteur, Paris, France<br />
P9-3 Serological assessment of the role of rodents as<br />
potential secondary reservoir during the West-<br />
African outbreak of the years 2014-2016<br />
Susanne M. Köhler, Robert Koch Institute, Berlin,<br />
Germany<br />
WS-10 Virus Structure and 20 th Oct. 2016<br />
Foyer D-G<br />
Imaging<br />
17:30 – 19:30<br />
P10-1 Real-time viral particle quantification and sizing:<br />
How biophysics supports virology<br />
Aure Saulnier, Sanofi Pasteur, Marcy l’Etoile, France<br />
P10-2 Amphipathic secondary structure elements and<br />
putative cholesterol binding domains (CRAC’s) as<br />
governing factors of high-specific matrix protein<br />
interactions with raft-type membrane in the<br />
enveloped viruses<br />
Victor Radyukhin, MV Lomonosov Moscow State<br />
University,A.N. Belozersky Institute of Physico-Chemical<br />
Biology, Moscow, Russian Federation<br />
P10-3 Investigation of the full-length nuclear export<br />
protein (NEP) of the influenza A virus in solution by<br />
small-angle X-ray scattering<br />
Victor Radyukhin, A.N. Belozersky Institute of Physico-<br />
Chemical Biology, Moscow State University, Moscow,<br />
Russian Federation<br />
P10-4 Potyvirus Potato Virus A coat protein posses unusual<br />
properties and forms short virus-like particles<br />
Alexander Ksenofontov, A.N. Belozersky Institute of<br />
Physico-Chemical Biology, Lomonosov Moscow State<br />
University, Moscow, Russian Federation<br />
P10-5 Cryo-EM structure of a new internal membrane ss-<br />
DNA-bacteriophage found in a boreal lake<br />
Luigi De Colibus, University of Oxford, Oxford, United<br />
Kingdom<br />
WS-11 Approved Antiviral 20 th Oct. 2016<br />
Hall E<br />
Therapies<br />
17:30 – 19:30<br />
P11-2 Predication of sofosbuvir response using a single<br />
nucleotide polymorphism of interferon lambda-4<br />
gene as a predictive factor<br />
Amal Saafan, Beni-Suef, Beni-Suef, Egypt<br />
WS-12 Pediatric Viral 20 th Oct. 2016<br />
Hall E<br />
Infections<br />
17:30 – 19:30<br />
P12-1 Epidemiology and clinical features of parechovirus<br />
infection among young children in Hong Kong<br />
Paul Chan, Chinese University of Hong Kong, Hong<br />
Kong SAR, China<br />
P12-3 Fast evaluation of hens and mouse anti-rotavirus<br />
A antibodies neutralization activity by developed<br />
real-time PCR-based protocol<br />
Aleksandra Nikonova, Mechnikov Research Institute<br />
for Vaccines and Sera, Moscow, Russian Federation<br />
P12-4 Detection and characterization of group C rotavirus<br />
in children in India<br />
Vasundhara Razdan Tiku, All India Institute of Medical<br />
Sciences (AIIMS)India, New Delhi, India<br />
P12-5 Viral etiology and characteristics of acute respiratory<br />
infections in hospitalized children in Zagreb<br />
region, Croatia<br />
Suncanica Ljubin-Sternak, School of Medicine, University<br />
of Zagreb, Zagreb, Croatia<br />
21<br />
WS-13 Antiviral Vaccines<br />
th Oct. 2016<br />
Hall E<br />
17:15 – 19:00<br />
P13-1 Establishment of the 3rd national reference standard<br />
for varicella vaccine in Korea<br />
Seokkee Chang, National Institute of Food and Drug<br />
Safety Evaluation, Cheongju-si, Korea, Republic of<br />
P13-3 FcgR-mediated phagocytosis by broadly protective<br />
influenza A virus IgGs<br />
Annasaheb Kolpe, Medical Biotechnology Center,<br />
VIB, Ghent, Belgium<br />
P13-4 Vaccination with Chimeric Newcastle Disease virus<br />
(NDV) improves protection after homologous<br />
challenge: The importance of cytoplasmatic tails in<br />
viral replication and protection<br />
Ray Izquierdo-Lara, FARVET SAC, Chincha Alta, Peru<br />
P13-5 Towards pre-defined rules for targeted viral<br />
genome re-encoding as a potential means of<br />
developing live-attenuated virus vaccines<br />
Raphaëlle Klitting, Aix-Marseille Univ - Institut de Recherche<br />
pour le Développement - Ecole des Hautes<br />
Etudes en Santé Publique, Marseille Cedex, France<br />
P13-6 Generation of Porcine Reproductive and Respiratory<br />
Syndrome (PRRS) virus-like-particles (VLPs)<br />
with different protein composition<br />
Marga Garcia Duran, INGENASA, Madrid, Spain<br />
P13-7 Double-stranded RNA molecules for TMV p126<br />
and CP genes, when applied exogenously, they<br />
induce resistance against TMV in tobacco<br />
Naga Charan Konakalla, Agricultural University of<br />
Athens, Athens, Greece<br />
P13-8 Corynebacterium cutis lysate treatment can<br />
changes the efficacies of PPR vaccine<br />
IRMAK Dik, University of Selcuk /Faculty of Veterinary<br />
Medicine, Konya, Turkey<br />
39
6 th<br />
European Congress of Virology<br />
40<br />
Poster Sessions<br />
WS-14 Emerging Topics in<br />
Veterinary Virology<br />
21 th Oct. 2016<br />
17:15 – 19:00<br />
Hall D<br />
P14-1 The genetic diversity of bovine papillomaviruses<br />
from different papillomatosis cases in Turkish cattle<br />
Seval Bilge Da alp, Ankara University Faculty of<br />
Veterinary Medicine, Ankara, Turkey<br />
P14-2 Applicability of contact sentinel mice for the<br />
detection of common viral pathogens in laboratory<br />
mouse husbandry Antje Rueckner, Leipzig University,<br />
Faculty of Veterinary Medicine, Leipzig, Germany<br />
P14-3 Reticuloendotheliosis virus (REV): Did it already<br />
arrive in Brazil?<br />
Giovana Santos Caleiro, Institute of Tropical Medicine<br />
of São Paulo, São Paulo, Brazil<br />
P14-4 Expression of p53 protein, Jaagsiekte sheep retrovirus<br />
matrix protein, and surfactant protein in the<br />
lungs of sheep with pulmonary adenomatosis<br />
Sevil Atalay Vural, Ankara University Faculty of Veterinary<br />
Medicine, Ankara, Turkey<br />
P14-5 A phylogenetic analysis of non-cytopathogenic<br />
Bovine viral Diarhhea virus isolates from heifers<br />
with respiratory disease<br />
Harun Albayrak, Ondokuz Mayis University, Samsun,<br />
Turkey<br />
P14-7 Porcine atypical pestiviruses in Austria<br />
Christiane Riedel, Vetmeduni Vienna, Vienna, Austria<br />
P14-9 Development of tools for diagnosis and prevention<br />
of Nodavirus outbreaks<br />
Carmen Galán, INGENASA, Madrid, Spain<br />
P14-10 Real-time PCR SYBR® Green-based detection<br />
assay for rapid screening and surveillance of<br />
Bornavirus<br />
Marlene Cavaleiro Pinto, Institute of Biomedical<br />
Sciences Abel Salazar, University of Porto, Porto,<br />
Portugal<br />
P14-12 Serologic signs of three important viral respiratory<br />
diseases of in various ruminants in small-sized<br />
enterprises, Turkey<br />
Harun Albayrak, Ondokuz Mayis University, Samsun,<br />
Turkey<br />
P14-13 Application of Rift Valley fever virus vaccines for<br />
camelids – safety, immunogenicity and pathogenicity<br />
of MP-12 vaccination of alpacas<br />
Melanie Rissmann, Friedrich-Loeffler-Institut, Greifswald,<br />
Germany<br />
P14-14 Differential interaction of gC1qR protein with the<br />
capsid proteins of porcine circoviruses<br />
Kouokam Fotso Guy Baudry, ANSES Ploufragan/Plouzané,<br />
Ploufragan, France<br />
P14-15 A comparison of virus concentration methods<br />
for molecular detection of infectious pancreatic<br />
necrosis virus (IPNV)<br />
Harun Albayrak, Ondokuz Mayis University, Samsun,<br />
Turkey<br />
P14-16 Clinical and necropsy findings of viral nervous and<br />
necrosis (VNN) in European seabass (Dicentrarchus<br />
labrax)<br />
Harun Albayrak, Ondokuz Mayis University, Samsun,<br />
Turkey<br />
WS-15 Oncogenic Mechanisms<br />
of Viruses<br />
21 th Oct. 2016<br />
17:15 – 19:00<br />
Foyer D-G<br />
P15-1 Viruses associated with female breast cancer<br />
Farbod Alinezhad, Faculty of Medicine, Urima<br />
University of Medical Sciences, Urmia, Iran, Islamic<br />
Republic of<br />
P15-2 The ORF012 gene of the oncogenic Marek’s<br />
disease virus type 1 encodes a novel SR-like phosphoprotein<br />
essential for virus growth<br />
Timo Schippers, Freie Universität Berlin, Berlin,<br />
Germany<br />
P15-3 Prevalence and characteristics of Epstein-Barr<br />
virus-associated gastric carcinomas in the centre<br />
of Portugal Célia Nogueira, Faculty of Medicine,<br />
University of Coimbra, Coimbra, Portugal<br />
P15-4 Role of HIV matrix protein p17 variants in lymphoma<br />
pathogenesis<br />
Arnaldo Caruso, University of Brescia Medical School,<br />
Brescia, Italy<br />
P15-5 The HTLV-1 oncoprotein Tax impacts Collagen type<br />
IV a1 and a2 (COL4A1 and COL4A2) in order to<br />
maintain a transformed phenotype of tumor cells<br />
Sebastian Millen, Friedrich-Alexander Universität<br />
Erlangen-Nürnberg, Erlangen, Germany<br />
P15-6 The VEGF/VEGFR pathway implicated in angiogenesis<br />
is deregulated in lung cancers induced<br />
by JSRV<br />
Maryline Gomes, UMR754 - INRA/Université Lyon 1,<br />
Lyon, France<br />
P15-7 Role of SUMO in the modulation of the PI3K/AKT<br />
pathway by influenza A virus NS1 protein<br />
Ahmed El Motiam, CIMUS/ Santiago de Compostela,<br />
Santiago de Compostela, Spain<br />
WS-16 Viral Latency and 21 th Oct. 2016<br />
Foyer D-G<br />
Persistence<br />
17:15 – 19:00<br />
P16-1 Human cytomegalovirus latent genome maintenance<br />
Daniela Pothmann, University of Regensburg,<br />
Regensburg, Germany<br />
P16-2 Thyroid gland as the site of human herpes virus 6<br />
persistence in patients with autoimmune thyroiditis<br />
Maksims Cistjakovs, RSU A.Kirchenstein Institute of<br />
Microbiology and Virology, Riga, Latvia<br />
P16-3 HHV-6 and HHV-7 associated changes in the frontal<br />
and temporal lobes of the brain of elderly subjects<br />
Sandra Skuja, Riga Stradins University, Riga, Latvia<br />
P16-4 Possible involvement of HHV-6 and HHV-7 infection<br />
in rheumatoid arthritis and osteoarthritis<br />
development Zaiga Nora-Krukle, Riga Stradins<br />
University, Riga, Latvia<br />
P16-5 A comparative epigenome and transcriptome<br />
analysis of KSHV and MHV68 latency<br />
Thomas Günther, Heinrich-Pette-Institute, Leibniz Institute<br />
for Experimental Virology, Hamburg, Germany<br />
P16-6 Complex quantification of the HIV reservoir in<br />
different CD4+ subsets including regulatory T-cells<br />
using a novel Droplet Digital PCR based approach<br />
Gabor Artur Dunay, Heinrich Pette Institute, Leibniz<br />
Institute for Experimental Virology, Hamburg,<br />
Germany<br />
P16-7 Kinetics of HIV-1 latency reversal and HIV-1 infection<br />
measured by a novel flow-based technique<br />
Gloria Martrus, Heinrich Pette Institute, Leibniz<br />
Institute for Experimental Virology, Hamburg,<br />
Germany
P16-8 Targeted HIV-1 latency reversal using CRISPR/<br />
Cas9-derived transcriptional activator systems<br />
Julia K. Bialek, Heinrich Pette Institute, Leibniz<br />
Institute for Experimental Virology, Hamburg,<br />
Germany<br />
P16-9 The pestiviral IFN antagonist Erns cleaves dsRNA<br />
as nicking endoribonuclease<br />
Carmela Lussi, Institute of Virology and Immunology<br />
(IVI), Federal Food Safety and Veterinary Office and<br />
Vetsuisse Faculty, Bern, Switzerland<br />
P16-10 In vitro evolution of persistent rabies virus: a role<br />
for IFN induction?<br />
Alexander Ghanem, LMU Munich, München, Germany<br />
WS-17 Experimental Antiviral<br />
Therapies<br />
21 th Oct. 2016<br />
17:15 – 19:00<br />
Hall E<br />
P17-1 Modeling of human papillomavirus infection in<br />
vitro: the influence of Proteflazid on the papillomavirus<br />
reproduction<br />
Darya Starosyla, L.V. Gromashevskiy Institute of<br />
Epidemiology and Infectious Diseases NAMSU, Kyiv,<br />
Ukraine<br />
P17-2 Antiviral activity of curcumin associated to nanoemulsions<br />
in HPV-16 E6 positive vulva cell lines<br />
Caroline Measso Bonfim Azol, Unesp, Sao Jose do<br />
Rio Preto, Brazil<br />
P17-4 Induction of transcription from the LCR of HPV-16<br />
by HDACi opposed by host-cell differentiation and<br />
episomal DNA maintenance<br />
Ekaterina Bojilova Albert, Université Libre de Bruxelles,<br />
Brussels, Belgium<br />
P17-5 Targeting the highly-conserved a2-helix of HPV E6<br />
oncoprotein: a new strategy for the development<br />
of anticancer drugs<br />
Lorenzo Messa, University of Padova, Padova, Italy<br />
P17-7 Use of multiplex real-time PCR assay for cellculture<br />
based testing of antiviral compounds with<br />
potential activity against human adenovirus C<br />
Tomasz Dzieciatkowski, Medical University of Warsaw,<br />
Warsaw, Poland<br />
P17-8 Inhibition of human Cytomegalovirus infection by<br />
the CRIPSR/Cas9 system<br />
Janina Gergen, INSERM, Nantes, France<br />
P17-9 Identification of small molecules inhibiting the<br />
dimerization of HCMV DNA polymerase processivity<br />
factor UL44<br />
Veronica Di Antonio, University of Padova, Padova,<br />
Italy<br />
P17-10 Antiviral activity of cerium dioxide nanoparticles in<br />
A-549 (lung human carcinoma) cell line<br />
Olga Shydlovska, National Academy of Sciences of<br />
Ukraine, D. K. Zabolotny Institute of Microbiology and<br />
Virology, Kyiv, Ukraine<br />
P17-11 Retinoblastoma cells are susceptible to terminase<br />
inhibitors<br />
Elke Bogner, Charité – Universitätsmedizin Berlin,<br />
Berlin, Germany<br />
P17-12 Tetrahologenated benzimidazole D-ribonucleosides<br />
are active against Rat Cytomegalovirus in 2-D<br />
as well as 3-D environment<br />
Elke Bogner, Charité – Universitätsmedizin Berlin,<br />
Berlin, Germany<br />
P17-13 G-Quadruplex mediated anti-HSV-1 activity of a<br />
core extended Napthalene Diimide compound<br />
Sara Callegaro, University of Padova, Padua, Italy<br />
P17-14 Gene therapy of AIDS: a novel approach combining<br />
anti HIV-1 siRNAs and a fusion inhibitor<br />
Arianna Calistri, University of Padova, Padova, Italy<br />
P17-15 Presence, function and targeting of G-quadruplexes<br />
in the HIV-1 LTR promoter<br />
Sara Richter, University of Padua, Padua, Italy<br />
P17-16 Evaluation of anti influenza virus activity of Peganumharmala<br />
L. seed extract in MDCK cell line<br />
Ali Karimi, Shahrekord University of Medical Sciences,<br />
Shahrekord, Iran, Islamic Republic of<br />
P17-17 Identification of novel nucleoside analogues that<br />
inhibit coronavirus replication<br />
Natacha Ogando, Leiden University Medical Center,<br />
Leiden, Netherlands<br />
P17-18 Co-culture of endothelial cells and monocytes as<br />
a potential model to study dengue pathogenesis<br />
and screen compounds with therapeutic potential<br />
Francielle Tramontini Gomes de Sousa Cardozo,<br />
University of Sao Paulo, Sao Paulo, Brazil<br />
P17-19 Combined application of antivirals against Coxsackievirus<br />
B3 infections in newborn mice<br />
Adelina Stoyanova, The Stephan Angeloff Institute of<br />
Microbiology, Bulgarian Academy of Sciences, Sofia,<br />
Bulgaria<br />
P17-21 AR-12, a novel host cell directed broad spectrum<br />
antiviral drug provides a survival benefit in the<br />
rabbit hemorrhagic fever model<br />
Stefan Proniuk, Arno Therapeutics, Flemington,<br />
United States<br />
P17-22 Squalamine – evaluation of antiviral properties of<br />
aminosterols from sharks<br />
Mihayl Varbanov, Université de Lorraine, Nancy,<br />
France<br />
P17-23 Antiviral activity of extracts isolated from Portuguese<br />
plants<br />
Célia Nogueira, Faculty of Medicine, University of<br />
Coimbra, Coimbra, Portugal<br />
WS-18 Highly Pathogenic 21 th Oct. 2016<br />
Hall E<br />
Viruses<br />
17:15 – 19:00<br />
P18-1 Longitudinal study on persistence and clearance of<br />
Ebola virus RNA from seminal fluid of Ebola virus<br />
disease survivors<br />
Stephan Günther, Bernhard Nocht Institute for<br />
Tropical Medicine, Hamburg, Germany<br />
P18-2 Ebola disease in Mauritian Cynomolgus macaques:<br />
Establishment of a model and analysis of virus<br />
populations<br />
Géraldine Piorkowski, UMR ‘Emergence des Pathologies<br />
Virales’ (EPV: Aix-Marseille University - IRD 190<br />
– Inserm 1207 – EHESP – IHU Méditerranée Infection),<br />
Marseille, France<br />
P18-3 Functional and structural analysis of Andes Virus L<br />
protein N-terminal domain, a potential pharmacological<br />
target<br />
Yaiza Fernandez-Garcia, Bernhard Nocht Institute for<br />
Tropical Medicine, Hamburg, Germany<br />
P18-4 Screening of vector populations for different<br />
arboviruses in Khartoum, Sudan by one-step realtime<br />
PCR Janine Michel, Robert Koch Institute, Berlin,<br />
Germany<br />
41
6 th<br />
European Congress of Virology<br />
42<br />
Poster Sessions<br />
WS-19 Viral Gene Expression<br />
– Transcription,<br />
Translation<br />
21 th Oct. 2016<br />
17:15 – 19:00<br />
Foyer D-G<br />
P19-1 Comparing the activity of the non-coding control<br />
region of 13 human polyomaviruses regarding<br />
bi-directional expression of the early and late viral<br />
gene region<br />
Elvis Ajuh Tasih, University of Basel/Institut für<br />
Medizinische Mikrobiologie, Basel, Switzerland<br />
P19-2 hnRNP L controls HPV16 mRNA splicing in an Aktkinase-dependent<br />
manner<br />
Stefan Schwartz, Lund University, Lund, Sweden<br />
P19-3 The human cytomegalovirus (HCMV) immediateearly<br />
protein IE2p86 negatively regulates<br />
transcription of lentiviral vectors leading to a shutdown<br />
of transgene expression<br />
Nina Reuter, Institute of Clinical and Molecular Virology,<br />
Erlangen, Germany<br />
P19-4 HHV-6 U94 inhibits motility, migration and invasiveness<br />
of human breast cancer cells by modulation<br />
of src signaling pathway<br />
Francesca Caccuri, University of Brescia, Brescia, Italy<br />
P19-5 HDV-GT3 demonstrates increased intrahepatic<br />
activity, distinct characteristics of the HDAg and<br />
enhanced HBV suppression compared to HDV-GT1<br />
in infected humanized mice<br />
Katja Giersch, University Medical Center Hamburg-<br />
Eppendorf, Hamburg, Germany<br />
P19-6 Decoding the Argonaute/viral RNA interaction<br />
map during HIV-1 replication using Ago2 HITS-CLIP<br />
Sarah Gallois-Montbrun, Institut Cochin – Inserm,<br />
U1016 – CNRS, UMR8104 – Paris Descartes University,<br />
Paris, France<br />
P19-7 Expression of hemagglutinin gene of avian influenza<br />
virus subtype H9 in Leishmania tarentolae<br />
Jahan Ara Begum, Institute of Virology, Leipzig,<br />
Germany<br />
P19-8 Coronavirus Nsp14 modulates the innate immune<br />
response<br />
Sonia Zuñiga, Centro Nacional de Biotecnologia<br />
(CNB-CSIC), Madrid, Spain<br />
P19-9 Structure dependent procession of non-structural<br />
polyprotein 7-10 and formation of a replicationtranscription<br />
complex of SARS Coronavirus<br />
Boris Krichel, Heinrich Pette Institute, Hamburg,<br />
Germany<br />
P19-10 N-terminal domain of Open Reading Frame 3<br />
(ORF3) gene of Porcine Epidemic Diarrhea Virus inducing<br />
cell death by cell arresting at the G1 phase<br />
Jihoon Ryu, Chungnam National University, Daejeon,<br />
Korea, Republic of<br />
P19-12 The role of translation termination factors in<br />
foot-and-mouth disease virus 2A peptide driven<br />
translational recoding<br />
Man Balola, Newcastle University, Newcastle, United<br />
Kingdom<br />
P19-13 Investigation into the structure of the nascent viral<br />
´2A´ peptide in the ribosomal exit tunnel.<br />
Pippa Harvey, Newcastle University, Newcastle upon<br />
Tyne, United Kingdom<br />
P19-14 Comparision of expression effectiveness of infectious<br />
pancreatic necrosis virus (IPNV) VP2 protein<br />
in three different Escherichia coli<br />
Harun Albayrak, Ondokuz Mayis University, Samsun,<br />
Turkey<br />
WS-20 Viral Vectors for<br />
Vaccine Design<br />
21 th Oct. 2016<br />
17:15 – 19:00<br />
Hall E<br />
P20-1 The protective role of tissue resident T cells<br />
against influenza infection by a CMV-based vaccine<br />
vector<br />
Xiaoyan Zheng, Helmholtz Centre for Infection<br />
Research, Braunschweig, Germany<br />
P20-4 DNA-launched RNA virus replicons based on yellow<br />
fever virus 17D<br />
Nadia Oreshkova, Leiden University Medical Center,<br />
Leiden, Netherlands<br />
WS-21 Viral Evolution and 19 th Oct. 2016<br />
Foyer D-G<br />
Resistance<br />
18:00 – 20:00<br />
P21-1 PAMM: A versatile approach exploring evolution<br />
across large phylogenies using mutational mapping<br />
Hui Chen, Genome Institute of Singapore, Singapore,<br />
Singapore<br />
P21-2 Origin and dissemination of hepatitis B virus<br />
genotype C in East Asia revealed by phylodynamic<br />
analysis and historical correlates<br />
Hsin-Fu Liu, Mackay Memorial Hospital, New Taipei<br />
city, Taiwan, Republic of China<br />
P21-3 Comparative study of in vivo evolution of hepaciviral<br />
glycoproteins in humans and horses<br />
Daniel Todt, TWINCORE, Centre for Experimental<br />
and Clinical Infection Research, Hannover, Germany<br />
P21-4 Production and characterisation of a hepatitis C<br />
virus cell culture (HCVcc) panel of patient-derived<br />
E1E2 glycoproteins for use in vaccine and therapy<br />
research Richard A Urbanowicz, The University of<br />
Nottingham, Nottingham, United Kingdom<br />
P21-5 Role of the PB1 protein in the fidelity of the influenza<br />
virus polymerase complex<br />
Florian Andrieux, Institut Pasteur, Paris, France<br />
P21-7 Intrahost norovirus evolution in chronic norovirus<br />
infection<br />
Andrej Steyer, Faculty of Medicine, University of<br />
Ljubljana, Ljubljana, Slovenia<br />
P21-8 Sequence variability of Puumala virus strain<br />
cg1820 Agnieszka M, Szemiel, MRC – University of<br />
Glasgow Centre for Virus Research, Glasgow, United<br />
Kingdom<br />
P21-9 Intertypic recombination of human parechovirus 4<br />
isolated from infants with sepsis-like disease<br />
Teemu Smura, University of Turku, Turku, Finland<br />
WS-22 Epidemiology and<br />
Surveillance<br />
19 th Oct. 2016<br />
18:00 – 20:00<br />
Hall D<br />
P22-1 Detection of Canine parvovirus type 2 by PCR in<br />
Konya IRMAK Dik, University of Selcuk /Faculty of<br />
Veterinary Medicine, Konya, Turkey<br />
P22-2 Accurate diagnosis of human Bocavirus 1 Infection<br />
by RT-PCR, qPCR and serology<br />
MAN XU, University of Helsinki, Helsinki, Finland<br />
P22-3 Molecular detection and phylogenetic analysis of<br />
Avipoxvirus strains isolated from different bird<br />
species Omid Madadgar, University of Tehran, Tehran,<br />
Iran, Islamic Republic of
P22-5 CMV seroprevalence among women of childbearing<br />
age and burden of congenital cytomegalovirus<br />
infection in Poland<br />
Tomasz Dzieciatkowski, Medical University of Warsaw,<br />
Warsaw, Poland<br />
P22-6 Molecular detection and genotyping of enteric<br />
viruses in children with acute gastroenteritis in<br />
Casablanca, Morocco<br />
Jalal Nourlil, Institut Pasteur du Maroc, Casablanca,<br />
Morocco<br />
P22-8 Application of molecular genotyping to determine<br />
prevalence of HPV strains among Kazakhstan<br />
women with abnormal Pap smear cytology<br />
Azliyati Azizan, Nazarbayev University, Astana,<br />
Kazakhstan<br />
P22-9 Detection of human papillomavirus in tissue biopsies<br />
from patients with head and neck squamous<br />
cell carcinoma in the Free State province, South<br />
Africa using E6 multiplex hemi-nested type specific<br />
PCR<br />
Tumelo Sekee, University of the Free State, Bloemfontein,<br />
South Africa<br />
P22-12 Seroprevalence of Hepatitis B, C and associated<br />
risk factors in hemodialysis units in Baghdad<br />
Baydaa Alabdali, Almustansiria, Baghdad, Iraq<br />
P22-15 Molecular epidemiology of Delta virus strains<br />
circulating in Central Italy<br />
Anna Rosa Garbuglia, INMI L SPALLANZANI IRCCS,<br />
Rome, Italy<br />
P22-16 Molecular characterisation of British Equine Infectious<br />
Anaemia cases, 1975-2012<br />
Bhudipa Choudhury, APHA, Weybridge, United<br />
Kingdom<br />
P22-17 Molecular epidemiological and serological studies<br />
of bovine leukemia virus (BLV) infection in Thailand<br />
Yeun-Kyung Shin, Animal and Plant Quarantine<br />
Agency, Gimcheon, Korea, Republic of<br />
P22-20 Molecular analyses of canine influenza viruses<br />
H3N2 isolated in Korea during 2013-2014<br />
Yeun-Kyung Shin, Animal and Plant Quarantine<br />
Agency, Gimcheon-si, Korea, Republic of<br />
P22-23 Survey of causative agents for acute respiratory<br />
infections among patients in Khartoum- State,<br />
Sudan, 2010-2011<br />
Khalid Enan, Central Laboratory – The Ministry of<br />
Higher Education and Scientific Research, Khartoum,<br />
Sudan<br />
P22-24 A study of Newcastle disease virus obtained from<br />
exotic caged birds in Tehran between 2009 and<br />
2010 Omid Madadgar, University of Tehran, Tehran,<br />
Iran, Islamic Republic of<br />
P22-25 Genomic characterization of novel avian paramyxovirus<br />
isolated from wild birds in Korea<br />
Kang-Seuk Choi, Animal and Plant Quarantine<br />
Agency, Gimcheon, Korea, Republic of<br />
P22-26 Epidemiologic investigations of a hospital cluster<br />
of Middle East Respiratory Syndrome outbreak in<br />
South Korea, 2015<br />
Changhwan Lee, KCDC, Cheongju, Korea, Republic of<br />
P22-27 Hospital outbreaks of Middle East Respiratory<br />
Syndrome in Daejeon, South Korea<br />
Jung Wan Park, KCDC, Cheongju, Korea, Republic of<br />
P22-28 Middle East Respiratory Syndrome Coronavirus<br />
outbreak in the Republic of Korea, 2015<br />
Seung Woo Kim, KCDC, Cheongju, Korea, Republic of<br />
P22-29 Risk factors for transmission of Middle East respiratory<br />
syndrome coronavirus infection during the<br />
2015 outbreak in South Korea<br />
Changhwan Lee, KCDC, Cheongju, Korea, Republic of<br />
P22-30 Epidemiologic features of the first MERS outbreak<br />
in Korea: focus on Pyeongtaek St. Mary’s Hospital<br />
Kyung Min, Kim KCDC, Cheongju, Korea, Republic of<br />
P22-31 The identification and characterization of pestivirus<br />
infections circulating among small ruminants,<br />
Turkey Tuba Cigdem Oguzoglu, Ankara University<br />
Veterinary Faculty, Ankara, Turkey<br />
P22-33 Continuous emergence and disappearance of<br />
sub-lineages of norovirus GII.4 Sydney 2012 during<br />
2012-2016 in Hong Kong<br />
Kirsty Kwok, The Chinese University of Hong Kong,<br />
Hong Kong, Hong Kong<br />
P22-34 Investigation of Bovine Enteric Caliciviruses among<br />
diarrheic calves in Turkey<br />
Ilke Karayel, Ankara University Faculty of Veterinary<br />
Medicine, Ankara, Turkey<br />
P22-35 Chikungunya and West Nile Viruses in Rwanda:<br />
Seroprevalence among blood donors and spread<br />
of mosquito-vectors<br />
Eric Seruyange, University of Gothenburg, Götenburg,<br />
Sweden<br />
P22-38 Preparation of recombinant antigen for serological<br />
detection of African hantaviruses<br />
Deborah Damane, University of the Free State,<br />
Bloemfontein, South Africa<br />
P22-39 The molecular characterisation of akabane virus<br />
from severe outbreak in 2015, Turkey<br />
FERAY Alkan, Ankara University Faculty of Veterinary<br />
Medicine, Ankara, Turkey<br />
P22-40 A systematic review of genetic diversity of human<br />
rotavirus circulating in South Korea<br />
Van Thai Than, Chung-Ang University, Seoul, Korea,<br />
Republic of<br />
P22-41 Genotyping and determining the distribution of<br />
prevalent G and P types of group A bovine rotaviruses<br />
between 2010 and 2012 in Iran<br />
Omid Madadgar, Faculty of Veterinary Medicine,<br />
University of Tehran, Tehran, Iran, Islamic Republic of<br />
P22-42 Genetic diversity and evolutionary analysis of<br />
rotavirus G2P[4] strains in South Korea: insights<br />
into the human and animal reassortment after<br />
vaccine introduction Thanh Hien Dang, Chung-Ang<br />
University, Seoul, Korea, Republic of<br />
WS-23 Infection of the Immunocompromised<br />
19 th Oct. 2016<br />
18:00 – 20:00<br />
Hall E<br />
P23-1 The potential role of viral infections on appearance<br />
of graft-versus-host disease on adult recipients of<br />
allogeneic haematopoietic stem cell transplantation<br />
in early post-transplant period<br />
Tomasz Dzieciatkowski, Medical University of Warsaw,<br />
Warsaw, Poland<br />
P23-2 Immunosuppressive therapy affects EBV- and<br />
HCMV-specific T-cell responses in patients with<br />
Systemic Lupus Erythematosus<br />
Irene Cassaniti, IRCCS Policlinico San Matteo, Pavia,<br />
Italy<br />
43
6 th<br />
European Congress of Virology<br />
Poster Sessions<br />
P23-3 Comparison of real-time PCR to ELISA for the<br />
detection of human Cytomegalovirus infection in<br />
renal transplant patients in the Sudan<br />
Khalid Enan, Central Laboratory – The Ministry of<br />
Higher Education and Scientific Research, Khartoum,<br />
Sudan<br />
P23-5 Human Immunodeficiency Virus and Strongyloides<br />
stercoralis infection in the United States of<br />
America, Laia Jimena<br />
Vazquez-Guillamet Yale New Haven Health-Bridgeport<br />
Hospital, Bridgeport, United States<br />
21<br />
WS-24 Zoonotic Viruses<br />
th Oct. 2016<br />
Hall D<br />
17:15 – 19:00<br />
P24-1 Hepatitis E Virus prevalence in British pigs at the<br />
time of slaughter<br />
Bhudipa Choudhury, APHA, Weybridge, United<br />
Kingdom<br />
P24-2 Molecular tracing of Hepatitis E virus in domestic<br />
pigs and wild boars from Corsica and possible<br />
foodborne transmissions in continental France<br />
Nicole Pavio, ANSES, Maisons-Alfort, France<br />
P24-3 Close genetic relatedness between human and<br />
swine hepatitis E viruses in Hong Kong<br />
Kirsty Kwok, The Chinese University of Hong Kong,<br />
Hong Kong, Hong Kong<br />
P24-4 Influenza A virus particles outside their hosts: is<br />
the Hemagglutinin a key factor for virus durability?<br />
Thomas Labadie, Institut Pasteur, Paris, France<br />
P24-5 Synthetically derived bat influenza A-like viruses<br />
reveal a cell type- but not species-specific tropism<br />
Martin Schwemmle, Institute of Virology, University<br />
Medical Center Freiburg, Freiburg, Germany<br />
P24-6 Role of the ciliary activity of the airway epithelium<br />
in the virus-host interaction<br />
Yuguang Fu, University of Veterinary Medicine Hannover,<br />
Hannover, Germany<br />
P24-7 Important viruses with zoonotic potential in South<br />
African bats: influenza A and hantaviruses<br />
Karmistha Poovan, Stellenbosch University, Cape<br />
Town, South Africa<br />
P24-8 Development of minireplicon systems for Tula and<br />
Dobrava-Belgrade hantaviruses<br />
Kirill Nemirov, Institute Pasteur, Paris, France<br />
P24-9 Human primary brain cells, a relevant model<br />
to study Tick-Borne Encephalitis Virus-induced<br />
neuropathogenesis<br />
Mazigh Fares, UMR 1161 Virology INRA/ANSES/<br />
ENVA, Maisons-Alfort, France<br />
P24-10 In vitro model of vector to host transmission:<br />
Langat and tick-borne encephalitis virus (LGTV<br />
and TBEV) infection of an embryonic Ixodes ricinus<br />
tick cell line and rat organotypic cerebellar culture<br />
slices to investigate viral quasispecies dynamics<br />
Nicole Lenz, University of Bern, Bern, Switzerland<br />
P24-11 Zoonotic variegated squirrel bornavirus 1: Detection<br />
in additional squirrel of two species<br />
Kore Schlottau, Friedrich-Loeffler-Institut, Greifswald -<br />
Insel Riems, Germany<br />
P24-12 Development of serological assays for the detection<br />
of henipavirus specific antibodies<br />
Kerstin Fischer, Friedrich-Loeffler-Institut, Greifswald -<br />
Insel Riems, Germany<br />
P24-13 Molecular epidemiology of an outbreak of<br />
Lymphocytic Choriomeningitis mammarenavirus<br />
infection in rodents and primates at a zoo in the<br />
United Kingdom<br />
Okechukwu, Onianwa, University of Nottingham, Nottingham,<br />
United Kingdom<br />
P24-14 Development and evaluation of a competitive<br />
enzyme-linked immunosorbent assay using a<br />
monoclonal antibody for diagnosis of severe fever<br />
with thrombocytopenia syndrome virus (SFTSV) in<br />
bovine sera<br />
Yeun-Kyung Shin, Animal and Plant Quarantine<br />
Agency, Gimcheon, Korea, Republic of<br />
WS-25 Curative Strategies<br />
for Virus Eradication<br />
20 th Oct. 2016<br />
17:30 – 19:30<br />
Hall E<br />
P25-1 Modified sabin 2 polioviruses for use as an oral-live<br />
attenuated vaccine post-eradication<br />
Matthijn de Boer, Intravacc, Bilthoven, Netherlands<br />
WS-26 Virus Discovery,<br />
Typing and Metagenomics<br />
21 th Oct. 2016<br />
17:15 – 19:00<br />
Hall D<br />
P26-1 Employment of next generation sequencing techniques<br />
for pathogen discovery in cerebrospinal<br />
fluid of patients with encephalitis and meningitis<br />
Cristina Freitas Nunes, Institute of Tropical Medicine<br />
of São Paulo, São Paulo, Brazil<br />
P26-2 Diagnostic metagenomics from respiratory<br />
samples significantly enhances the detection rate<br />
of pathogens in allogenic HSCT patients with<br />
pulmonary complications<br />
Nicole, Fischer, University Medical Center Hamburg-<br />
Eppendorf, Hamburg, Germany<br />
P26-3 Circulation of influenza D virus in cattle in Italy<br />
Chiara Chiapponi, Istituto Zooprofilattico Sperimentale<br />
della Lombardia e dell’Emilia Romagna, Parma,<br />
Italy<br />
P26-5 Discovery of novel avian polyomaviruses<br />
Kristin Heenemann, Leipzig University, Faculty of<br />
Veterinary Medicine, Leipzig, Germany<br />
P26-6 PCR standardization for full Trichodysplasia<br />
Spinulosa-associated Polyomavirus (TSPyV) to<br />
sequencing using sanger methodology and nextgeneration<br />
sequencing Paulo Roberto Urbano,<br />
Institute of Tropical Medicine of São Paulo, São Paulo,<br />
Brazil<br />
P26-7 Retrospective genetic and phylogenetic study of<br />
orthobunyaviruses circulating in Russia<br />
Alexey Mikhailovich Shchetinin, Gamaleya Federal<br />
Research Center for Epidemiology and Microbiology,<br />
Ministry of Health of the Russian Federation, Moscow,<br />
Russian Federation<br />
P26-8 The molecular-biological properties and physicochemical<br />
characterization of an iridovirus from<br />
mosquito Aedes flavescents<br />
Yuriy Rud, Institute of Fisheries, Kyiv, Ukraine<br />
P26-9 Unusual large dsDNA viruses discovered among<br />
genome data of 15 different fish<br />
Amr Aswad, University of Oxford, Oxford, United<br />
Kingdom<br />
44
WS-27 Vector Borne Infections<br />
21 th Oct. 2016<br />
17:15 – 19:00<br />
Hall D<br />
P27-1 Evidence of wild birds participating in Toscana<br />
virus dissemination and perpetuation<br />
Sabri Hacioglu, Ankara University Faculty of Veterinary<br />
Medicine, Ankara, Turkey<br />
P27-2 Latest Zika virus outbreak: lessons learnt from the<br />
perspective of the “European Virus Archive goes<br />
Global (EVAg)” EU funded consortium<br />
Christine Prat, Aix-Marseille Univ – Institut de Recherche<br />
pour le Développement – Ecole des Hautes<br />
Etudes en Santé Publique, Marseille, France<br />
P27-3 First imported case of Zika virus infection in China,<br />
diagnosis and genomic analysis<br />
Shuo Zhang, National Institute for Viral Disease Control<br />
and Prevention, China CDC, Beijing, China<br />
P27-4 Virus and antibody kinetics in acute Zika virus<br />
infection Luisa Barzon, University of Padova, Padova,<br />
Italy<br />
P27-5 Persistent shedding of Zika virus RNA in semen<br />
Luisa Barzon, University of Padova, Padova, Italy<br />
P27-6 Development and evaluation of an enzyme-linked<br />
immunosorbent assay for the detection of IgM antibodies<br />
to Zika Virus in human serum and plasma<br />
Elke Heck, NovaTec Immundiagnostica GmbH,<br />
Dietzenbach, Germany<br />
P27-7 Arbo-MIA: An innovative platform for accurate<br />
high-throughput diagnosis and surveillance of Zika<br />
virus and arboviral infections<br />
Jessica Vanhomwegen, Institut Pasteur, Paris, France<br />
P27-10 Concurrent micro-RNA mediated silencing of tickborne<br />
flavivirus replication in tick vector and in the<br />
brain of vertebrate host<br />
Konstantin A. Tsetsarkin, NIAID, Bethesda, United<br />
States<br />
P27-11 Mosquito borne infectious diseases across borders,<br />
risks, challenges and mangement with reference to<br />
dengue virus<br />
Mamdouh El Bahnasawy, Military Medical Academy,<br />
Cairo, Egypt<br />
P27-12 Proteomic profiling of Aedes albopictus infected<br />
with chikungunya virus or dengue virus provides<br />
new insights into vector-arbovirus interactions<br />
Vincent Legros, Pasteur Institut, Paris, France<br />
P27-13 Dengue fever presenting as acute airway obstruction:<br />
a case report<br />
Manidipa Majumdar, R G Kar Medical College and<br />
Hospital, Kolkata, India<br />
P27-14 MK3, a novel host factor, is essential for Chikungunya<br />
virus protein translation in vitro<br />
Prabhudutta Mamidi, Institute of Life Sciences,<br />
Bhubaneswar, India<br />
P27-15 Characterization of nsP1 and nsP2 interaction of<br />
Chikungunya virus<br />
Sameer Kumar, Institute of Life Sciences, Bhubaneswar,<br />
India<br />
P27-16 Chikungunya importation risks from Thailand to<br />
Europe regions during the period of 2008 – 2015:<br />
What they mean<br />
Hatsadee Appassakij, Prince of Songkla University,<br />
Faculty of Medicine, Hat Yai, Thailand<br />
P27-17 A temporary imported chikungunya virus infection<br />
in non-immune travellers returning from the<br />
outbreak activity at popular tourist destinations in<br />
Southern Thailand during 2008 – 2015<br />
Hatsadee Appassakij, Prince of Songkla University,<br />
Faculty of Medicine, Hat Yai, Thailand<br />
P27-18 Diagnosis of West Nile virus infection: Experience<br />
in a reference laboratory, Italy, 2008 – 2015<br />
Luisa Barzon, University of Padova, Padova, Italy<br />
P27-19 Identification of T cell epitopes on the nucleoprotein<br />
of Crimean-Congo haemorrhagic fever virus<br />
Dominique Goedhals, National Health Laboratory<br />
Service/University of the Free State, Bloemfontein,<br />
South Africa<br />
P27-20 A case of Crimean-Congo hemorrhagic fever and a<br />
general review in Egypt<br />
Mamdouh El Bahnasawy, Military Medical Academy,<br />
Cairo, Egypt<br />
P27-21 Crimean-Congo haemorrhagic fever virus detected<br />
in patient with suspected rickettsia infection:<br />
increasing awareness within endemic countries and<br />
for travelers Felicity Burt, NHLS and University of the<br />
Free State, Bloemfontein, South Africa<br />
P27-22 Molecular detection of Crimean-Congo hemorrhagic<br />
fever virus (CCHFV) in tick samples but not<br />
in blood and milk samples in northern Turkey<br />
Harun Albayrak, Ondokuz Mayis University, Samsun,<br />
Turkey<br />
P27-23 Rift Valley fever virus P78 glycoprotein as a mosquito<br />
specific virulence factor<br />
Felix Kreher, University of Glasgow, Glasgow, United<br />
Kingdom<br />
P27-24 Epidemiological investigation of severe fever with<br />
thrombocytopenia syndrome<br />
Shuo Zhang, National Institute for Viral Disease Control<br />
and Prevention, China CDC, Beijing, China<br />
45
46<br />
6 th<br />
European Congress of Virology
Speakers‘ Index<br />
Page<br />
Akkutay-Yoldar, Zeynep Ankara University, Faculty of Veterinary Medicine, Ankara, Turkey. . . . . . . . . 23<br />
Allen, Todd Ragon Institute of MGH, MIT and Harvard, Cambridge MA, USA . . . . . 30, 31<br />
Andrei, Graciela Rega Institute, KU Leuven, Belgium . . . . . . . . . . . . . . . . . 20<br />
Ar Gouilh, Meriadeg Institut Pasteur, Paris, France . . . . . . . . . . . . . . . . . . . . 31<br />
Asbach, Benedikt University of Regensburg, Regensburg, Germany . . . . . . . . . . . . 29<br />
Bahar, Mohammad Waleed Division of Structural Biology, Oxford, UK . . . . . . . . . . . . . . . 29<br />
Bailly, Benjamin Institute for Glycomics, Gold Coast, Australia . . . . . . . . . . . . . . 25<br />
Bartenschlager, Ralf University Hospital Heidelberg, Germany . . . . . . . . . . . . . . . 28<br />
Bartusch, Christina<br />
University Medical Center of the<br />
Johannes Gutenberg University Mainz, Mainz, Germany . . . . . . . . . 22<br />
Barzon, Luisa University of Padova, Padova, Italy. . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Baumert, Thomas F. INSERM, University of Strasbourg, France. . . . . . . . . . . . . . . . . . . . . 31, 55<br />
Baz-Martínez, Maite<br />
Centro de Investigación en Medicina Molecular y Enfermedades Crónicas<br />
(CiMUS), Santiago de Compostela, Spain . . . . . . . . . . . . . . . . . . . . . . . 28<br />
Beer, Martin Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany . . . . . . . . . . . . 27<br />
Belarbi, Essia CEA, Fontenay aux Roses, France . . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Benkirane, Monsef Institut de Génétique Humaine, Montpellier, France . . . . . . . . . . . . . . . . 55<br />
Benn, Paul ViiV Healthcare, London, UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />
Berezin, Vladimir Institute of Microbiology and Virology, Almaty, Kazakhstan . . . . . . . . . . . . 26<br />
Berlioz-Torrent, Clarisse INSERM, Paris, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />
Billerbeck, Eva The Rockefeller University, New York, USA . . . . . . . . . . . . . . . . . . . . . . 22<br />
Biquand, Elise Institut Pasteur, Paris, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />
Blanc, Stéphane INRA-CIRAD-Supagro, Montpellier, France . . . . . . . . . . . . . . . . . . . . . . 32<br />
Blöcker, Johanna University Medical Center Hamburg-Eppendorf, Hamburg, Germany . . . . . . 22<br />
Boianelli, Alessandro Helmholtz Centre for Infection Research, Braunschweig, Germany . . . . . . . . 24<br />
Bosse, Jens Bernhard<br />
Heinrich Pette Institute, Leibniz Institute for Experimental Virology,<br />
Hamburg, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Bresk, C. Anika Medical University Innsbruck, Innsbruck, Austria . . . . . . . . . . . . . . . . . . . 29<br />
Brown, Martha University of Toronto, Toronto, Canada . . . . . . . . . . . . . . . . . . . . . . . . 28<br />
Brown, Richard J. P.<br />
TWINCORE, Centre for Experimental and Clinical Infection Research,<br />
Hannover, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />
Buchholz, Frank TU Dresden, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31<br />
Buggisch, Peter IFI Medicine, Hamburg, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . 55<br />
Burkard, Christine University of Edinburgh, Roslin, UK . . . . . . . . . . . . . . . . . . . . . . . . . . 26<br />
Caignard, Grégory UMR 1161 ANSES-INRA-ENVA, Maisons-Alfort, France. . . . . . . . . . . . . . . 26<br />
Campadelli-Fiume, Gabriela University of Bologna, Italy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21, 28<br />
Carroll, Miles W. Public Health England, Salisbury, UK. . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Castaño-Rodríguez, Carlos Centro Nacional de Biotecnologia (CNB-CSIC), Madrid, Spain . . . . . . . . . . 28<br />
Catanese, Maria Teresa King’s College London, London, UK . . . . . . . . . . . . . . . . . . . . . . . . . . 22<br />
Chappell, Joe University of Nottingham, Nottingham, UK . . . . . . . . . . . . . . . . . . . . . . 32<br />
Ching, Wilhelm<br />
Heinrich Pette Institute, Leibniz Institute for Experimental Virology,<br />
Hamburg, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27<br />
Chiocca, Susanna European Institute of Oncology, Milano, Italy . . . . . . . . . . . . . . . . . . . . 26<br />
Colpitts, Che C.<br />
Inserm U1110, Institut de Recherche sur les Maladies Virales et Hépatiques,<br />
Strasbourg, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />
Cornberg, Markus Medical University Hannover, Hannover, Germany. . . . . . . . . . . . . . . . . . 55<br />
47
6 th<br />
European Congress of Virology<br />
Speakers‘ Index<br />
Page<br />
Cortez-San Martín, Marcelo Universidad de Santiago de Chile, Santiago, Chile . . . . . . . . . . . . . . . . . 29<br />
Cullen, Bryan R. Duke University Medical Center, Durham NC, USA . . . . . . . . . . . . . . . . . 28<br />
Czech-Sioli, Manja University Medical Center Eppendorf, Hamburg, Germany . . . . . . . . . . . . 31<br />
Dahlke, Christine University Medical Center Eppendorf, Hamburg, Germany . . . . . . . . . . . . 26<br />
Dai, Meiling Utrecht University, Utrecht, The Netherlands . . . . . . . . . . . . . . . . . . . . . 31<br />
Dallmeier, Kai KU Leuven - University of Leuven, Leuven, Belgium . . . . . . . . . . . . . . . . . 26<br />
Dao Thi, Viet Loan Rockefeller University, New York, USA . . . . . . . . . . . . . . . . . . . . . . . . . 31<br />
Davidson, Irit Kimron Veterinary Institute, Bet Dagan, Israel . . . . . . . . . . . . . . . . . . . . 22<br />
De Spiegelaere, Ward Ghent University, Belgium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22<br />
de Haan, Cornelis A.M. Utrecht University, Utrecht, The Netherlands . . . . . . . . . . . . . . . . . . . . . 30<br />
Declercq, Marion Institut Pasteur, Paris, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />
Dehn, Sandra Michaela University Clinic Tübingen, Tübingen, Germany . . . . . . . . . . . . . . . . . . . 20<br />
Delwart, Eric University of California, San Francisco CA, USA . . . . . . . . . . . . . . . . . 31, 32<br />
Deschermeier, Christina Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany . . . . . . . 22<br />
Desole, Giovanna University of Padova, Padova, Italy. . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Diederich, Sandra Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Germany . . . . . . . . . . . 22<br />
Diskin, Ron Weizmann Institute of Science, Rehovot, Israel . . . . . . . . . . . . . . . . . . . . 21<br />
Drosten, Christian University of Bonn, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
Dubich, Tatyana Helmholtz Centre for Infection Research, Braunschweig, Germany . . . . . . . . 27<br />
Dudek, Alexandra University of Freiburg, Freiburg, Germany . . . . . . . . . . . . . . . . . . . . . . 20<br />
Durantel, David INSERM, Lyon, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />
Fargette, Denis IRD, Université Montpellier 2, Montpellier, France. . . . . . . . . . . . . . . . . . 27<br />
Fehse, Boris Univesity Medical Center Eppendorf, Hamburg, Germany . . . . . . . . . . . . . 55<br />
Feldmann, Heinz NIAID, NIH, Hamilton MT, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />
Fertey, Jasmin Fraunhofer-Institute for Cell Therapy and Immunology, Leipzig, Germany . . . . 26<br />
Fiorentini, Simona University of Brescia, Brescia, Italy . . . . . . . . . . . . . . . . . . . . . . . . . 25, 30<br />
Furnon, Wilhelm UMR 754 INRA - University Claude Bernard Lyon 1, IVPC, Lyon, France . . . . . 32<br />
Ganem, Don Novartis Institutes for Biomedical Research, Emeryville CA, USA . . . . . . . . . 20<br />
Ganges, Llilianne IRTA, Barcelona, Spain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27<br />
Garcia, J. Victor University of North Carolina, Chapel Hill NC, USA. . . . . . . . . . . . . . . . . . 23<br />
Garzino Demo, Alfredo University of Padova, Padova, Italy. . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Geijtenbeek, Teunis B. University of Amsterdam, The Netherlands . . . . . . . . . . . . . . . . . . . . . . 20<br />
Gonzalez-Almela, Esther Universidad Autónoma de Madrid, Madrid, Spain. . . . . . . . . . . . . . . . . . 20<br />
Goulder, Philip University of Oxford, UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22<br />
Grandi, Nicole University of Cagliari, Monserrato (Cagliari), Italy . . . . . . . . . . . . . . . . . . 32<br />
Greber, Urs University of Zurich, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />
Hage, Elias Hannover Medical School, Hannover, Germany . . . . . . . . . . . . . . . . . . . 30<br />
Harrer, Thomas Universitätsklinikum Erlangen, Erlangen, Germany . . . . . . . . . . . . . . . 22, 31<br />
Hassan, Ebrahim University of Freiburg, Freiburg, Germany . . . . . . . . . . . . . . . . . . . . . . 20<br />
Hedman, Klaus University of Helsinki, Helsinki, Finland . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
Hirsch, Hans University of Basel, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
Hoffmann, Hans-Heinrich The Rockefeller University, New York, USA . . . . . . . . . . . . . . . . . . . . . . 22<br />
Horemheb-Rubio, Gibran National Institute of Medical Science and Nutrition, Mexico City, Mexico . . . . 31<br />
Imperiale, Michael J. University of Michigan, Ann Arbor MI, USA . . . . . . . . . . . . . . . . . . . . . . 21<br />
Izquierdo, Laure AP-HP Paul Brousse Hospital, Villejuif, France . . . . . . . . . . . . . . . . . . . . 23<br />
Jo, Wendy K. University of Veterinary Medicine, Hannover, Germany . . . . . . . . . . . . . . . 32<br />
Kaiser, Rolf University of Cologne, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
48
Kellam, Paul Welcome Trust Sanger Institute, Cambridge, UK . . . . . . . . . . . . . . . . . . 31<br />
Khou, Cecile Institut Pasteur, Paris, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Klingen, Thorsten Ralf Helmholtz Centre for Infection Research, Braunschweig, Germany . . . . . . . . 30<br />
Koethe, Susanne Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany . . . . . . . . . . . . 22<br />
Komatsu, Tetsuro Université de Bordeaux, Bordeaux, France . . . . . . . . . . . . . . . . . . . . . . 20<br />
Koopmans, Marion Erasmus MC, Rotterdam, The Netherlands . . . . . . . . . . . . . . . . . . . . 30, 31<br />
Kotta-Loizou, Ioly Imperial College London, London, UK . . . . . . . . . . . . . . . . . . . . . . . . 32<br />
Lavillette, Dimitri Institut Pasteur Shanghai, Shanghai, China . . . . . . . . . . . . . . . . . . . . 21, 32<br />
Lazear, Helen M. University of North Carolina, Chapel Hill NC, USA. . . . . . . . . . . . . . . . . . 32<br />
Leopardi, Stefania Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy . . . . . . . . 31<br />
Li, Sai University of Oxford, Oxford, UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Liljeström, Peter Karolinska Institutet, Stockholm, Sweden . . . . . . . . . . . . . . . . . . . . . . . 29<br />
Lilleri, Daniele Fondazione IRCCS Policlinico San Matteo, Pavia, Italy . . . . . . . . . . . . . . . 22<br />
Limonta, Daniel University of Alberta, Edmonton, Canada . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Lingappa, Vishwanath R. Prosetta Biosciences, San Francisco CA, USA . . . . . . . . . . . . . . . . . . . . 22<br />
Lotke, Rishikesh Hanover Medical School, Hannover, Germany . . . . . . . . . . . . . . . . . . . . 27<br />
Lucifora, Julie University of Lyon, Lyon, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55<br />
Lusic, Marina University of Heidelberg, Heidelberg, Germany . . . . . . . . . . . . . . . . . . . 55<br />
Malim, Michael H. King’s College London, UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />
Masucci, Maria Karolinska Institutet, Stockholm, Sweden . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Mcilroy, Dorian<br />
INSERM, Center for Research in Transplantation and Immunology (CRTI),<br />
Nantes, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
Mesalam, Ahmed Atef Ghent University, Ghent, Belgium . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />
Mettenleiter, Thomas Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany . . . . . . . . . . 22, 26<br />
Moreno del Olmo, Elena Centro de Biología Molecular Severo Ochoa-CSIC-UAM, Madrid, Spain. . . . . 30<br />
Münz, Christian University of Zurich, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Muscolino, Elena<br />
Heinrich Pette Institute, Leibniz Institute for Experimental Virology,<br />
Hamburg, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />
Nikonova, Aleksandra<br />
Mechnikov Research Institute for Vaccines and Sera,<br />
Moscow, Russian Federation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25<br />
Nour, Islam King Saud University, Riyadh, Saudi Arabia . . . . . . . . . . . . . . . . . . . . . . 30<br />
Oestereich, Lisa Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany . . . . . . . 28<br />
Osterhaus, Albert University of Veterinary Medicine Hannover, Germany . . . . . . . . . . . . . 31, 32<br />
Pantaleo, Guiseppe University of Lausanne, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . 26<br />
Papa, Anna Aristotle University of Thessaloniki, Greece . . . . . . . . . . . . . . . . . . . . . . 28<br />
Peralta, Zuleyma Icahn School of Medicine at Mount Sinai, New York, USA . . . . . . . . . . . . . 28<br />
Pesavento, Patricia School of Veterinary Medicine, UC Davis, Davis, USA . . . . . . . . . . . . . . 23, 26<br />
Pfänder, Stephanie<br />
TWINCORE - Centre for Experimental and Clinical Infection Research,<br />
Hannover, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Pietsch, Corinna Leipzig University, Leipzig, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . 25<br />
Ping, Yueh-Hsin National Yang-Ming University, Taipei, Taiwan, Republic of China . . . . . . . . . 21<br />
Pischke, Sven University Medical Center Eppendorf, Hamburg, Germany . . . . . . . . . . . . 25<br />
Ploss, Alexander Princeton University, Princeton NJ, USA. . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Quirin, Tania University of Helsinki, Helsinki, Finland . . . . . . . . . . . . . . . . . . . . . . . . 21<br />
Raj, V. Stalin<br />
Department of Viroscience, Erasmus Medical Center,<br />
Rotterdam, The Netherlands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26<br />
Rey, Félix A. Institut Pasteur, Paris, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Riedel, Christiane Vetmeduni Vienna, Vienna, Austria. . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />
49
6 th<br />
European Congress of Virology<br />
Speakers‘ Index<br />
Page<br />
Rivas, Carmen CIMUS, Santiago de Compostela, Spain . . . . . . . . . . . . . . . . . . . . . . . 27<br />
Rockstroh, Jürgen Bonn University Hospital, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Rodriguez, Estefania<br />
Heinrich Pette Institute, Leibniz Institute for Experimental Virology,<br />
Hamburg, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27<br />
Rübsamen-Schaeff, Helga University of Frankfurt, Wuppertal, Germany . . . . . . . . . . . . . . . . . . . . . 32<br />
Ruibal, Paula<br />
Heinrich Pette Institute, Leibniz Institute for Experimental Virology,<br />
Hamburg, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />
Samreen, Baila Heinrich Heine University of Düsseldorf, Düsseldorf, Germany . . . . . . . . . . 26<br />
Sas, Miriam A. Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany . . . . . . . . . . . . 30<br />
Scheel, Troels K. H. University of Copenhagen, Copenhagen, Denmark . . . . . . . . . . . . . . . . . 28<br />
Schlabe, Stefan University Hospital Bonn, Bonn, Germany. . . . . . . . . . . . . . . . . . . . . . . 24<br />
Schmid, Michael A. University of California Berkeley, Berkeley, USA . . . . . . . . . . . . . . . . . . . 32<br />
Schmiedel, Dominik Hebrew University of Jerusalem, Jerusalem, Israel. . . . . . . . . . . . . . . . . . 20<br />
Schoofs, Till The Rockefeller University, New York City, USA. . . . . . . . . . . . . . . . . . . . 28<br />
Schubert, Grit Robert Koch-Institute, Berlin, Germany . . . . . . . . . . . . . . . . . . . . . . . . 31<br />
Seuberlich, Torsten<br />
University of Bern, NeuroCenter-Division of Neurological Sciences,<br />
Bern, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26<br />
Shah, Pranav Uniklinikum, Heidelberg Universität, Heidelberg, Germany . . . . . . . . . . . . 24<br />
Shaw Stewart, Patrick Douglas Instruments Ltd, Hungerford, UK. . . . . . . . . . . . . . . . . . . . . . . 30<br />
Shtykova, Eleonora<br />
Shubnikov Institute of Crystallography, Russian Academy of Sciences,<br />
Moscow, Russian Federation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Sikorski, Mathieu UMR 1064 - CRTI, Nantes, France . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
Snijder, Eric Leiden University Medical Center, Leiden, The Netherlands . . . . . . . . . . . . 28<br />
Sola, Isabel CNB-CSIC, Madrid, Spain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />
Souza, William Marciel University of Sao Paulo, Ribeirão Preto, Brazil . . . . . . . . . . . . . . . . . . . . 32<br />
Stech, Jürgen Friedrich-Loeffler-Intitut, Greifswald - Insel Riems, Germany . . . . . . . . . . . . 28<br />
Steinbach, Falko APHA, Addlestone, United Kingdom . . . . . . . . . . . . . . . . . . . . . . . . . 26<br />
Steinhagen, Katja Institute for Experimental Immunology, Euroimmun AG, Luebeck, Germany . . 23<br />
Stellbrink, Hans-Jürgen ICH, Hamburg, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25, 55<br />
Stertz, Silke University of Zurich, Zurich, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . 21<br />
Stiasny, Karin Medical University of Vienna, Vienna, Austria . . . . . . . . . . . . . . . . . . . . 24<br />
Strati, Katerina University of Cyprus, Nicosia, Cyprus . . . . . . . . . . . . . . . . . . . . . . . . . 27<br />
Suarez, Nicolas MRC - University of Glasgow, Glasgow, UK . . . . . . . . . . . . . . . . . . . . . . 30<br />
Szalmas, Anita University of Debrecen, Debrecen, Hungary . . . . . . . . . . . . . . . . . . . . . 27<br />
Taher, Husam Institute for Infection Medicine, Kiel, Germany . . . . . . . . . . . . . . . . . . . . 29<br />
Tai, Julie Weizmann Institute of Science, Rehovot, Israel . . . . . . . . . . . . . . . . . . . . 28<br />
Teo, Su Hui Catherine Imperial College, London, United Kingdom . . . . . . . . . . . . . . . . . . . . . 28<br />
Theiss, Juliane University Medical Center Eppendorf, Hamburg, Germany . . . . . . . . . . . . 27<br />
Todt, Daniel<br />
TWINCORE - Centre for Experimental and Clinical Infection Research,<br />
Hannover, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
Tommasino, Massimo International Agency for Research on Cancer, Lyon, France . . . . . . . . . . . . 26<br />
Tong, Jie University of Veterinary Medicine Hannover, Hannover, Germany . . . . . . . . . 31<br />
Toppinen, Mari University of Helsinki, Helsinki, Finland . . . . . . . . . . . . . . . . . . . . . . . . 27<br />
Tordo, Noël Institut Pasteur, Paris, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31<br />
Towner, Jonathan CDC, Atlanta GA, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27<br />
Trkola, Alexandra University of Zurich, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Überla, Klaus Universitätsklinikum Erlangen, Erlangen, Germany . . . . . . . . . . . . . . . 20, 24<br />
50
Uetrecht, Charlotte Heinrich Pette Institute, Leibniz Institute for Experimental Virology /<br />
European XFEL, Hamburg, Germany. . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Ulbrich, Pavel University of Chemistry and Technology Prague, Prague, Czech Republic . . . . 24<br />
Urban, Stephan University Hospital Heidelberg, Germany . . . . . . . . . . . . . . . . . . . . . . . 20<br />
Urbanowicz, Richard A The University of Nottingham, Nottingham, UK . . . . . . . . . . . . . . . . . . . 30<br />
Väisänen, Elina University of Helsinki, Helsinki, Finland . . . . . . . . . . . . . . . . . . . . . . . . 32<br />
van Boemmel, Florian University Medical Center, Leipzig, Germany. . . . . . . . . . . . . . . . . . . . . 55<br />
van der Poel, Wim H. Wageningen University, The Netherlands . . . . . . . . . . . . . . . . . . . . . . . 26<br />
van der Werf, Sylvie<br />
University Paris Diderot-Sorbonne Paris Cité, Institut Pasteur,<br />
Paris, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22<br />
van Kuppeveld, Frank Utrecht University, Utrecht, The Netherlands . . . . . . . . . . . . . . . . . . . . . 21<br />
Varjak, Margus MRC-University of Glasgow Centre for Virus Research, Glasgow, UK . . . . . . . 32<br />
Vermeire, Tessa WIV-ISP, Ukkel, Belgium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />
Victorio, Carla Bianca Luena Temasek Life Sciences Laboratory, Singapore, Singapore. . . . . . . . . . . . . . 25<br />
Viejo-Borbolla, Abel Hannover Medical School, Hannover, Germany . . . . . . . . . . . . . . . . . . . 27<br />
Vietzen, Hannes Medical University of Vienna, Vienna, Austria . . . . . . . . . . . . . . . . . . . . 24<br />
Volz, Asisa LMU Munich, Munich, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . 26, 29<br />
Vonderstein, Kirstin Umeå University, Umeå, Sweden . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />
Wagner, Ralf University of Regensburg, Regensburg, Germany . . . . . . . . . . . . . . . . 22, 26<br />
Westhölter, Dirk University Hospital Hamburg-Eppendorf, Hamburg, Germany. . . . . . . . . . . 31<br />
Wichgers Schreur, Paul<br />
Central Veterinary Institute, Part of Wageningen UR and Research Centre,<br />
Lelystad, The Netherlands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />
Widjaja, Ivy Utrecht University, Utrecht, The Netherlands . . . . . . . . . . . . . . . . . . . . . 21<br />
Wolf, Dana Hadassah Medical Center, Jerusalem, Israel . . . . . . . . . . . . . . . . . . . . . 25<br />
Wüstenhagen, Elena<br />
Johannes Gutenberg-University Mainz,<br />
Mainz, Germany. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />
Yassine, Hadi Qatar University, Doha, Qatar. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />
Yim, Seung-Ae Inserm, U1110, Strasbourg, France . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />
Zakaryan, Hovakim Institute of Molecular Biology of NAS, Yerevan, Armenia . . . . . . . . . . . . . . 32<br />
Zhernov, Yury<br />
National Research Center – Institute of Immunology FMBA of Russia,<br />
Moscow, Russian Federation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32<br />
51
6 th<br />
European Congress of Virology<br />
Congress Dinner &<br />
Networking Event<br />
Join us for a communicative evening – think back to the lectures and discussions of the day<br />
and meet familiar and new branch colleagues! You can expect a buffet with local and international<br />
influence and corresponding drinks.<br />
When? Friday, October 21, 19:00 - 24:00<br />
Where?<br />
Price:<br />
Congress Center Hamburg (Hall 3, Ground Floor)<br />
55,00 f<br />
Tickets for this evening were limited (“first come – first served”). Please ask at the registration desk if there<br />
are still tickets available.<br />
Prices include 19% German VAT; in the name and for account of INTERPLAN AG, Kaiser-Wilhelm-Str. 93, 20355 Hamburg,<br />
Germany, Ust.-ID DE 21327487.<br />
52
Symposia<br />
Satellite Symposia<br />
ANRS / DZIF Satellite Symposium<br />
HBV and HIV Cure<br />
Friday, 21 th October<br />
Saturday, 22 th October<br />
Thursday, 20 th October<br />
13:15 – 14:45<br />
13:15 – 14:45<br />
13:15 – 14:15<br />
HBV and<br />
HIV Cure<br />
Emerging<br />
Zoonoses<br />
Challenges in<br />
Clinical Virology<br />
Novel<br />
Technologies for<br />
Improved<br />
Pathogen<br />
Detection<br />
Chairs Brigitte Autran, Brigitte Autran, Paris, France<br />
Martin Krönke, Cologne, Germany<br />
13:15 – 14:00 HBV<br />
Functional genomics of HBV-host interactions to discover novel targets for<br />
viral cure<br />
Thomas Baumert, Strassburg, France<br />
Interactions between HBV, HDV and the hepatocytes: insights into the<br />
development of new antivirals<br />
Julie Lucifora, Lyon, France<br />
Stopping nucleos(t)die analogues in HBeAg negative chronic hepatitis B<br />
as concept to induce HBsAg decline<br />
Markus Cornberg, Hannover, Germany<br />
14:00 – 14:45 HIV<br />
HIV integration and cellular fate<br />
Marina Lusic, Heidelberg, Germany<br />
Understanding HIV latency in resting CD4 T cells<br />
Monsef Benkirane, Montpellier, France<br />
High-efficiency TALEN-mediated knockout of HIV co-receptor CCR5 –<br />
a promising approach to confer resistance against R5-tropic HIV<br />
Boris Fehse, Hamburg, Germany<br />
Erasmus MC / Institut Pasteur Satellite Symposium<br />
Emerging Zoonoses<br />
Chairs<br />
13:15 – 14:45<br />
<strong>Programme</strong> to be announced on-site.<br />
Chairs<br />
Chairs<br />
13:15 – 14:45<br />
ESV Satellite Symposium<br />
Challenges in Clinical Virology<br />
Knud Schewe, Hamburg, Germany<br />
Julian Schulze zur Wiesch, Hamburg, Germany<br />
Pushing the borders of HBV treatment: New treatment approaches and<br />
biomarkers<br />
Florian van Boemmel, Leipzig, Germany<br />
No more challenges in HCV?<br />
Peter Buggisch, Hamburg, Germany<br />
Is it only the virus, stupid?<br />
Hans-Jürgen Stellbrink, Hamburg, Germany<br />
Industry Symposia<br />
QIAGEN Satellite Symposium<br />
Novel Technologies for Improved Pathogen Detection<br />
Instant success: setting new standards for safe and easy pathogen detection<br />
by real-time PCR<br />
Francesca Di Pasquale, Hilden, Germany<br />
53
54<br />
6 th<br />
European Congress of Virology
Sponsors<br />
We cordially thank the following companies for their support:<br />
Platinum Sponsor:<br />
Gold Sponsor:<br />
Silver Sponsors:<br />
We also thank MDPI for an unrestricted educational grant.<br />
Support According to National Compliance Requirements<br />
A listing of support according to national compliance requirements can be found at<br />
www.eurovirology2016.eu/fsa-list.html.<br />
The sponsoring companies do not have input into the development of the meeting.<br />
55
6 th<br />
European Congress of Virology<br />
Exhibiton List<br />
Acris-Antibodies-OriGene EU GERMANY G.03<br />
Advanced Cell Diagnostics ITALY G.16<br />
AID Diagnostika GmbH GERMANY G.18<br />
altona Diagnostics GmbH GERMANY G.01<br />
Biocartis NV BELGIUM G.17<br />
BioLegend UNITED STATES OF AMERICA G.26<br />
Biomatters NEW ZEALAND G.35<br />
Bio-Rad Laboratories UNITED KINGDOM G.28<br />
BIO-SYS GERMANY G.33<br />
CTL Europe GmbH GERMANY G.29<br />
dianova GmbH GERMANY G.24<br />
DZIF Academy<br />
Deutsches Zentrum für Infektionsforschung GERMANY G.38<br />
eBioscience part of Themo Fischer Scientific AUSTRIA G.10<br />
Eppendorf AG GERMANY G.13<br />
EUROIMMUN AG GERMANY G.22<br />
European Society for Virology GERMANY G.38<br />
Gilead Sciences Europe Ltd. UNITED KINGDOM G.09<br />
Heinrich Pette Institute,<br />
Leibniz Institute for Experimental Virology GERMANY G.37<br />
I&L Biosystems GERMANY G.23<br />
Instand e.V. GERMANY G.34<br />
Labotect Labor-Technik-Göttingen GmbH GERMANY G.19<br />
LI-COR Biosciences GERMANY G.15<br />
Lophius Biosciences GmbH GERMANY G.32<br />
Luminex THE NETHERLANDS G.07<br />
MACHEREY-NAGEL GmbH & CO. KG GERMANY G.30<br />
MEDICAL WIRE AND EQUIPMENT UNITED KINGDOM G.02<br />
Microbiology Society UNITED KINGDOM G.14<br />
Mikrogen GmbH GERMANY G.04<br />
Miltenyi Biotec GERMANY G.25<br />
MSD SHARP & DOHME GMBH GERMANY G.11<br />
Novatec Immundiagnostica GmbH GERMANY G.27<br />
Oxford Immunotec UNITED KINGDOM G.36<br />
PeproTech GERMANY G.12<br />
PerkinElmer GERMANY G.21<br />
QIAGEN GmbH GERMANY G.06<br />
SARSTEDT AG & Co GERMANY G.08<br />
Takara Bio Europe FRANCE G.05<br />
Vela Diagnostics GERMANY G.31<br />
Zymo Research Europe GmbH GERMANY G.20<br />
56<br />
A listing of support according to national compliance requirements can be found at<br />
www.eurovirology2016.eu/fsa-list.html.
Exhibition Floor Plan<br />
i<br />
HALL G<br />
G.30 G.31<br />
G.39<br />
G.10 G.11<br />
G.17<br />
G.29<br />
G.32<br />
G.38<br />
G.05<br />
G.26 G.27<br />
G.37<br />
G.04<br />
G.09<br />
G.25<br />
G.28<br />
G.36<br />
G.03<br />
G.07<br />
G.14<br />
G.13 G.15<br />
G.22 G.23<br />
G.35<br />
G.02<br />
G.06<br />
G.08<br />
G.12<br />
G.16<br />
G.21<br />
G.24<br />
G.34<br />
G.01<br />
G.18 G.19 G.20<br />
G.33<br />
Entrance<br />
Entrance<br />
57
58<br />
6 th<br />
European Congress of Virology
Congress Center Hamburg Overview<br />
2 nd Floor<br />
HALL 1<br />
HALL F<br />
HALL G /<br />
EXHIBITION<br />
HALL E<br />
HALL D<br />
FOYER HALL D-G<br />
FOYER HALL 1<br />
Registration<br />
1 st Floor<br />
C3<br />
C1<br />
C2*<br />
HALL B<br />
FOYER<br />
A-C<br />
Cloakroom<br />
Hall 1<br />
HALL A<br />
*Media Check<br />
59
6 th<br />
European Congress of Virology<br />
Notes<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
60
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
61
6 th<br />
European Congress of Virology<br />
Notes<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
62
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />
63
Change language